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Sudden cardiac death constitutes over a quarter of
the total mortality from coronary heart disease in man.
The cause of these deaths is assumed to be the cardiac
rhythm disturbance, ventricular fibrillation (VF).
Any intervention which might reduce VF is of major
clinical importance. Diets enriched with unphysio-
logically large quantities of the polyunsaturated fatty
acid (PUFA), 18:2(n-6) have been shown to reduce
ventricular fibrillation in animals. However, such
diets also result in reciprocal changes in other
nutrients. The primary aim of this thesis was to con¬
firm the antiarrhythmic effect of 18:2(n-6) on
ischaemic arrhythmias using balanced semi-synthetic
diets and to determine its mechanism. Arrhythmias were
studied during coronary artery ligation (20 minutes) in
the isolated rat heart, Langendorff perfused with a
modified Krebs-Henseleit buffer (K+=3.0mM). The influ¬
ence of these diets on myocardial phospholipid fatty
acid composition was also examined.
Ischaemic VF was studied in inbred rats fed a stand¬
ardised semi-synthetic control diet (PUFA/saturated
fatty acid ratio (P/S) 0.3) to identify an arrhythmia
prone strain. The results suggested a genetic influence
on the incidence of VF which was associated with
altered fat metabolism.
Dietary recommendations aimed at reducing heart
disease include a decrease in total fat intake to 30%
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energy. The effect of different total fat diets (20,
30, 40% energy) v/ith high or low PUFA (n-6) levels on
the incidence of ischaemic VF was studied. As reported
previously, an antiarrhythmic effect was observed with
the high fat, high P/S ratio diet. This effect was
maintained at 30% energy from fat, but at 20% energy
this protective effect was attenuated. Myocardial PUFA
phospholipid distribution (bar arachidonic acid) was
altered with high PUFA diets. Correlations with the
incidence of VF were found between dietary saturated
(r=0.825) and polyunsaturated (r=-0.925) fatty acids.
An unexpected pattern towards an increased number of
fatty acid changes with a reduction in total fat from
40 to 30 to 20% energy was found.
Diets are enriched with PUFA's at the detriment of
saturated fatty acids. To distinguish between these two
factors an experiment was designed to determine the
relative importance of dietary saturated fat, PUFA fat
and the P/S ratio to ischaemic VF. The dominant factor
was found to be the P/S ratio.
Indomethacin, a non-steroidal anti-inflammatory
drug has been shown to diminish the antiarrhythmic
effect of high PUFA diets. The more selective cyclo-
oxygenase inhibitor flurbiprofen did not reduce the
antiarrhythmic effect of high PUFA diets.
The effect of fish oil (rich in PUFA of the n-3
family) on ischaemic arrhythmias was also studied. This
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was to determine whether the antiarrhythmic effect was
a general PUFA property or specific to the n-6 essen¬
tial PUFA's. The results from feeding realistic amounts
of fish oil (0.4% kCal as (n-3) fatty acids) showed a
trend towards an antiarrhythmic effect.
In conclusion, the most important antiarrhythmic
dietary factor is the P/S ratio, associated with PUFA
incorporation into myocardial cell membrane phospho¬
lipid. This could modulate membrane function without an
alteration in prostanoid release, and thereby the prop¬
ensity for ischaemic arrhythmias.
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Coronary heart disease is the commonest cause of
death in the Western world. The precise cause of this
disease is still unknown but the identification of a
number of risk factors from epidemiological studies has
helped to reduce mortality in some countries (Figure
1.1). However, coronary heart disease continues to be
Britains greatest public health problem with death
rates amongst the highest in the world [1 ].
FIGURE 1.1 Standardised coronary heart disease
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Understanding of coronary heart disease is compli¬
cated by geographical variation within and between
countries and by the complex inter-relationships bet¬
ween the various risk factors. Furthermore, coronary
heart disease encompasses several clinical conditions
including angina pectoris, myocardial infarction and
sudden cardiac death. This thesis is specifically con¬
cerned with sudden cardiac death and the role of
dietary fat in the prevention of this event.
1 .2 Coronary heart disease.
1.2.1 Epidemiology and identification of the risk
factors of coronary heart disease.
Numerous epidemiological studies have been carried
out since the end of World War II, when the mortality
rate from coronary heart disease began to increase in
many Western countries [3]. Only one epidemiological
study has monitored sudden cardiac death alone and the
bulk of the data discussed refers to total coronary
heart disease mortality. Three early studies have gen¬
erated most of the information about the classical risk
factors of coronary heart disease;
1. The International Atherosclerosis Project (IAP) [4].
2. The Seven Countries study [5].
3. The Framingham Heart Study [6].
The IAP involved investigators in 14 countries
(1960-1965) in the examination of arterial specimens
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(aortic, coronary, cerebral, carotid and vertebral) of
men and women aged 10-69 years at autopsy using a
standard, protocol. The major conclusion of this study
was that everyone has some degree of atherosclerosis.
Accelerated conditions were primarily linked with
environmental conditions and geographical location but
not race or age. Furthermore the identification of many
individuals with severe atherosclerosis but without
clinical coronary heart disease and others with below
average lesions who had demonstrated coronary heart
disease indicated that atherosclerosis was not the sole
determinant of coronary heart disease.
The Seven Countries study is probably the most
carefully controlled study undertaken to date which
assessed the risk factors for coronary heart disease in
geographically and culturally distinct groups. Measure¬
ments of blood pressure, cholesterol, cigarette
smoking, physical activity, age and body mass were
taken from all individuals. The initial data was
obtained from men aged 40-59 years (during 1957-1962)
and followed up with reference to coronary heart
disease at 5 and 10 years. This study identified serum
total cholesterol concentration as a key factor in
determining the risk of coronary heart disease.
Further, total cholesterol correlated with the percen¬
tage of total energy provided by saturated fats (Figure
1.2).
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FIGURE 1.2 Relationship between dietarty saturated
fatty acids and serum total cholesterol comparing
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Other suspected factors such as high blood
pressure, cigarette smoking, lack of physical activity,
age and increased body mass were stated to be relevant
only when the serum total cholesterol was high. The
conclusion could equally have been that all the factors
including serum total cholesterol were only relevant if
saturated fat intake was high. It should be noted that
different countries had variations in the importance of
certain risk factors and cholesterol was the only
finding common to all communities. Analysis of a possi¬
ble effect of dietary polyunsaturated fat on adipose
tissue was not undertaken but the cohorts with the
lowest mortality rates had the highest percentage of
linoleic acid in their diet and vice versa for popula¬
tions with the highest mortality rates.
The Framingham heart study in the USA started in
1948 and continues to the present day involving some
5000 men and women aged 30-59 years in the town of
Framingham. It has provided valuable information rela¬
ting possible risk factors to angina, myocardial infar¬
ction, sudden cardiac death and total coronary heart
disease. This study identified elevated cholesterol
levels, gender, smoking, lack of physical exercise,
excess body weight and elevated blood pressure as risk
factors for coronary heart disease within a population
[7]. It should be noted that no information on dietary
fat intake was available from this study. However, this
18
study did investigate individually the relationship of
risk factors with myocardial infarction, angina and
sudden cardiac death individually. The 20-year follow-
up showed the risk factors for total coronary heart
disease, myocardial infarction and angina to be
similar. Sudden cardiac death lacked a relationship
with elevated cholesterol but was still related to all
the other risk factors, especially smoking which held a
4 fold increase in risk.
Epidemiological studies in Britain have identified
similar trends in all the risk factors with the
noteable exception of total serum cholesterol [8], [9].
The Edinburgh - Stockholm study [10] identified a 3-
fold excess mortality from coronary heart disease,
associated with low linoleic acid concentrations in
adipose tissue, plasma triglycerides and plasma choles¬
terol esters. The involvement of dietary linoleic acid
in coronary heart disease had been hypothesised very
early on by the nutritionist Sinclair [11], but the
data supporting this hypothesis has been inconclusive
[12] [13]. The primary reason was the incorrect choice
of population to study and the use of an inadequate
control group. Furthermore it is diffiicult to succes¬
sfully monitor dietary intake in the normal population.
The Finish study overcame this problem by studying a
group of institutionised mental patients, however it
could be critised because this was not a normal cross-
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section of the poulation. Epidemiological data has also
identified a possible involvement of dietary eicosapen-
tanoic acid from fish in the reduction of coronary
heart disease [14] [15] [16], while others have found
no relationship [17].
1.2.2 Sudden cardiac death.
Sudden death is poorly understood and by nature
its management is difficult. Discrepancies in the clas¬
sification of sudden ischaemic death contribute to the
lack of understanding of this condition. For example,
there are publications on "sudden death" [18] [19] and
"sudden unexpected death" from the Framingham study
[20]. No correlation was found between "sudden death"
and serum cholesterol, but suprisingly in 1984, "sudden
unexpected death" had a strong relationship with serum
cholesterol (p<0.034). This might reflect some time-
dependent process, but there was clearly a change in
classification. In the earlier publications the
condition v/as defined as "death occurring within 1 hour
of symptoms" whereas in 1984 the definition was that of
"death occurring within 1 hour of onset of symptoms
without prior overt CHD and without other probable
cause of death suggested by medical history". This
discrepancy in classification renders interpretation of
the results in the 1984 publication open to consider¬
able debate. The now widely accepted definition, used
20
in this thesis, is that of "death due to cardiac causes
within one hour of the onset of acute symptoms in an
individual with or without known heart disease" [21].
The fatal event in sudden cardiac death is most
commonly the onset of the lethal cardiac rhythm distur¬
bance, (arrhythmia), ventricular fibrillation [22].
Ventricular fibrillation may accompany acute myocardial
infarction [23] and/or acute myocardial ischaemia [24]
precipitated by coronary artery thrombus formation [25]
or spasm [26] against the background of coronary heart
disease. Significantly the common post-mortem finding
in cases of sudden ischaemic death is that of severe
coronary atherosclerosis [27], However, not all
patients with known atherosclerosis die suddenly
and individuals with electrolyte imbalance [28], drug
intoxication [29] or congenital electrophysiological
abnormalities (eg long QT syndrome [30]) can also
develop ventricular fibrillation.
The identification of specific risk factors in
sudden cardiac death is poorly documented because of
the non-uniformity of classification explained above.
However, from the data available, the risk factors
predicting sudden cardiac death over the course of
decades (20-26 years) do appear to be similar to those
for coronary heart disease [31]. This is not suprising
as statistically 90% of all sudden deaths occur in
individuals with existing coronary heart disease [32].
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1.2.3 Prevention of sudden cardiac death.
The previous section illustrated the lack of basic
knowledge of the factors leading to sudden cardiac
death. The early identification of those individuals at
particular risk of arrhythmias is rarely successful and
the treatments available for this population are
limited. Improvements in identification may come with
prolonged holter ECG monitoring [33] and new develop¬
ments such as body surface mapping [34] and/or high
fidelity ECG recordings [35],
VF can be readily reversed by the D.C. discharge
from an electronic defibrillator, however such equip¬
ment is not readily available in the community. The
introduction of the surgically implantable defibrill¬
ator has been shown to be effective in the prevention
of sudden cardiac death [36]. But, the effect of fre¬
quent defibrillation of the heart may be detrimental
and use is currently restricted to patients who have
already demonstrated a serious arrhythmia and survived.
Primary prevention strategies aimed at a reduction
in the classical risk factors for CHD; smoking, choles¬
terol, hypertension, etc have had limited success as
evidenced by the decline in coronary heart disease
mortality in the United States with no change in the
fraction of sudden deaths [19].
Conventionally drug treatment is only introduced
after an arrhythmic event. The Class 1 antiarrhythmic
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rugs are the most common agents prescribed to indivi¬
duals who survive such an episode. However, these drugs
have side effects including bradycardia, hypotension,
gastrointestinal upset and allergic reactions [37] and
can also prove to be pro-arrhythmic. Indeed a recent
attempt to assess the benifits of the prophylactic
antiarrhythmic drug treatment, flecainide, in a
selected population produced the disturbing finding of
increased mortality in one of the treated groups [38]
giving rise to considerable concern.
In conclusion, there is no factor which has been
identified which is effective in primary prevention and
the treatment available to prevent recurrence is less
than ideal.
1.2.4 Diet and sudden cardiac death.
Experiments in animals have identified a possible
antiarrhythmic effect of the essential fatty acid lino-
leic acid [39] [40] [41]. After feeding animals stan¬
dard laboratory diets supplemented with vegetable oil
rich in (n-6) polyunsaturated fatty acids the incidence
of ventricular fibrillation due to acute coronary
artery ligation was found to be reduced.
Dietary recommendations by the World Health
Organisation [42] and the COMA Committee [43] stated
that a reduction in total and saturated fat intake was
desirable. There were no recommendations regarding
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polyunsaturated fatty acids. The Seven Countries Study
[5] identified a relationship between low P/S ratio
and coronary heart disease mortality (Figure 1.3). The
effect was assumed to be solely due to reduced
saturated fat, which caused a reduction in serum total
cholesterol and inturn a reduction in coronary heart
disease. However, the link between cholesterol and
coronary heart disease remains controversial [44] [45]
[46] and the decline in heart disease observed in the
USA may be in part due to an increased P/S ratio, and
increased polyunsaturated fat intake, not decreased
total and saturated fat.
Further work confirming linoleic acid was
definitely responsible for the reduction in VF in the
animal experiments using isocalorific diets could
provide an ideal low cost method for reducing mortality
from sudden cardiac death in man.
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FIGURE 1.3 Ratio of polyunsaturated to saturated fats
and the incidence of coronary heart disease (per 100
000 population per year) in men aged 40-59 in the Seven
Countries Study [ 5 ] (Greece = Corfu and Crete, but
as data for polyunsaturated fatty acids for Crete were
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1.3 Dietary fat.
In recent years dietary fathas been linked to
various diseases including cancer and heart disease
[47] [48] [49], This has led to a great deal of
conflicting advice on what one should or should not
eat. Fat is required by the body as an energy source,
and as a precursor for the biosynthesis of membranes
and prostanoids.
Dietary fat is consumed predominantly as tri¬
glyceride. Every triglyceride consists of three
glycerol hydroxy groups each esterified with a fatty
acid. The fatty acids are a combination of saturated,
monounsaturated or polyunsaturated molecules (throu¬
ghout the thesis the "(n-*)" nomenclature is used for
fatty acids [50]. This method specifies the number of
carbon atoms and double bonds and. identifies the posi¬
tion of the first double bond from the methyl terminus
of the fatty acid). All the double bonds are cis and
are separated one from another by a single Cf^ group.
These two features evoke a large variety of possible
molecular conformation increasing with the number of
double bonds present. The number of possible conforma¬
tions which may be assumed by arachidonic acid have
been calculated by Jong et al [51] and are illustrated
in Figure 1.4.
26
FIGURE 1.4 Some possible conformations of arachidonic
acid from Jong et al [51].
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Saturated, monounsaturated and polyunsaturated
fatty acids are synthesised by the body (endogenously)
as well as being consumed in the diet (exogenously).
Mammals are unable to synthesise 18:2(n-6) and 18:3(n-
3) fatty acids as they do not possess the necessary
enzymes. Therefore, certain polyunsaturated fatty acids
(PUFA's) can only be obtained from the diet and are
essential for normal growth [52]. These are classified
as the n-6 and n-3 families, which are not interconver¬
tible (Figure 1.5). The major effects of n-6 essential
fatty acid deficiency are shown in Table 1.1.
FIGURE 1.5 Essential polyunsaturated fatty acids of the




6-Desaturase Elongase 5-Desaturase Elongase
18:2 (N-6) ► 18:3(N-6) ► 20:3(N-6) ► 20:4(N-6) ► 22:4(n-6)
Linoleic 7 Linolenic Dihommo- Arachidonic Docosatetr-
linolenic aenoic
PARENT DERIVATIVES
(N-3) . 1 ,
18:3 (N-3) _*.18:4(N-3) 20:4(N-3) _► 20:5(N-3) 22:5(n-3) 22:6(N-3)
a Linolenic Eicosapentaenoic Docosa-
hexaenoic
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TABLE 1.1 The major effects of n-6 EFA deficiency in
the rat.
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(a)Changes in the fatty acid
composition of most organs.
(b)Increase in cholesterol levels
in liver, adrenal and skin.
(c)Decrease in plasma cholesterol.
(d)Changes in the swelling of heart




synthesis and release by the liver.
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These effects are not alleviated by n-3 PUFA's. N-3
PUFA's were only identified as necessary for normal
mammalian learning and behaviour relatively recently
[53] .
What controls the destination of specific fatty
acids and their functions is therefore of considerable
importance in the understanding of their involvement in
various disease states. This section summarises the
literature in this expanding area.
1.3.1 Fatty acids as an energy source.
Fatty acids in the form of triglycerides consti¬
tute a major source of fuel in animals and oil bearing
plants. Triglycerides supply 38 kJoules of energy per
gram [54] and are therefore a more concentrated form of
fuel than either protein or carbohydrate which each
supply about 17 kJ/g. As a fuel fatty acids may be
required for immediate oxidation or held in reserve for
future use. The liver is primarily concerned with pro¬
cessing glycerides for immediate usage and redistri¬
bution to other tissues for oxidation or storage. This
area is not discussed, but the reader is referred to
the review by Josef Patsch [55] which summarises the
recent literature on dietary lipid transport.
When energy supply from triglycerides exceeds
energy demand, they are deposited in adipose tissue for
energy storage. Adipose tissue consists of adipocytes
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bound together with connective tissue and supplied with
nutrients by a network of capillaries. The adipocyte
can either store fat from the circulation or synthesise
its own from carbohydrate. Each cell stores triglyce¬
rides in the less bulky anhydrous form and has the
capacity for a large increase in size, which cannot be
achieved with glycogen energy stores.
Fatty acids are the major source of energy for the
myocardium [56] as opposed to the brain which preferen¬
tially requires glucose. In mammals there tends to be a
distinction between the types of fatty acids fulfilling
a storage role and those involved in a structural role
in membranes. In general terms, polyunsaturated fatty
acids are involved in a structural role whereas sat¬
urated and monounsaturated fatty acids are sources of
energy. The fatty acid composition of adipose tissue in
man illustrates this phenomenon with saturated and
monounsaturated fatty acids composing approximately 30
and 50% respectively whereas polyunsaturates only rep¬
resent 10% most of which is 18:2(n-6) [57],
Several publications have identified low adipose
an
tissue linoleic acid level asjindependant risk factor
of coronary heart disease [10] [58]. The half-life of
adipose tissue fatty acids is nearly one year [59] and
the relative amount of linoleic acid in adipose tissue
is directly related (r=0.68) to the amount consumed
[60] [61]. Because of itsaccessibility, adipose tissue
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biopsy is the favoured means of measuring linoleic acid
in many epidemiology studies. Follow-ups of these
studies show that the low adipose levels are due to
decreased dietary intake of linoleic acid [62]. The
relevance of these adipose tissue findings to part¬
icular functions of the myocardium is as yet unknown.
However in man there is a good relationship between
adipose and myocardial 18:2(n-6) levels (RA Riemersma,
unpublished data).
1.3.2 Fatty acids and membranes.
Membranes of all organelles in the body are
composed of lipid and proteins. The lipid in membranes
exists as phospholipids, glycolipids, and cholesterol
esters. The four principal phospholipids are phospha¬
tidylcholine, phosphatidlyserine, phosphatidylethanol-
amine and phosphatidylinositol. In the myocardium the
phospholipid cardiolipin is also abundant. Each phos¬
pholipid molecule has a glycerol backbone with an
esterified fatty acid at carbons 1 and 2, but unlike
triglyceride the 3 carbon has a phosphate group with
either choline, serine, ethanolamine or inositol
attached to it. The fatty acids vary in chain length
and saturation depending on diet and hormonal status.
Unsaturated fatty acids are usually found at carbon 2,
whereas saturated fatty acids are found at carbon 1.
The preferential choice of polyunsaturated fatty acids
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to the Sn2-hydroxyl group may be to allow the first CH2
segment to be parallel to the surface of the membrane
before assuming a perpendicular orientation within the
membrane [63]. This suggests the need for the first CE^
segment of the hydrocarbon backbone to be accessible to
the outer or inner side of the membrane, possibly for
cleavage by phospholipase.
The polarity of the phosphate moiety determines
the transverse asymmetry of the phospholipid membrane
with the hydrophobic portion of the molecule on the
inside and the hydrophilic portion on the outside. In
human erythrocytes 75% phosphatidylcholine, 80% sphin¬
gomyelin and 20% phosphadidylethanolamine are localised
in the outer leaflet of the membrane and amino phospho-
glycerides such as phosphatiylserine and phosphatidyl-
ethanolamine are preferentially present on the internal
side of the membrane [64]. The asymmetric distribution
of lipids in membranes has posed important questions
about the mechanism of phospholipid biosynthesis,
topology of the corresponding enzymes and translocation
[65] .
The phospholipid biosynthetic pathways of

































































































The base exchange between phosphatidylserine and
phosphatidyl ethanolamine or phosphatidylcholine as
well as the enzymatic methylation of phosphatidyl etha¬
nolamine to phosphatidyl choline, illustrate mechanisms
whereby the polarity of the phospholipid membrane can
be easily modified [67] [68]. The independant exchange
of fatty acids on preformed phospholipids is a further
method by which phospholipids may be tailored for a
specific function.
The predominant polyunsaturated fatty acid found
in human phospholipid membranes is arachidonic
acid, 20:4(n-6). Every phospholipid fraction has a
distinctive highly conserved fatty acid pattern. For
example, in rat myocardial phosphatidylserine 22:6(n-3)
is the predominant fatty acid whereas in phosphatidyl-
inositol 20:4n-6 is the major fatty acid [69]. The
control and function of these specific fatty acid
patterns is poorly understood. Further, the molecular
species of the phospholipid fractions appears to be
organ dependent, as demonstrated in PI of muscle, brain
and retina by Bell et al [70],
Dietary fat can alter the fatty acid composition
of membrane phospholipids. In recent years this area
has been entensively studied. Data on dietary induced
changes in the fatty acid composition of membrane phos¬
pholipids in various organs are now available. In this
thesis only the results from heart tissue analyses are
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discussed. The use of a wide variety of dietary fats of
differing doses and duration in numerous animal species
makes this a very confusing area. The majority of work
to date has studied the effects of the dietary essen¬
tial fatty acids of the n-6 and n-3 families on total
myocardial phospholipids.
Diets enriched with corn oil, sunflower oil and
safflov/er oil all contain large quantities of the
essential fatty acid linoieic acid (18:2(h-6)). After
feeding such diets (up to 14% w/w linoieic acid with
extreme P/S ratios as large as 7.2 [71]) for varying
time periods from 1 week to 20 months the myocardial
fatty acid composition was altered [72] [73] [74].
However there was no change in the amounts of fatty
acids incorporated into phospholipids and the P/S ratio
was maintained [75] [76]. The consistent finding in all
the publications was an increase in specific polyun¬
saturated fatty acids in total phospholipids with sat¬
urated and monounsaturated fatty acids unaltered. The
greatest variation was the increase in myocardial total
phospholipid linoieic acid [74] [39], The results for
arachidonic acid levels are notably inconsistent, with
some experimentalists finding no changes [77] [78],
while others documented increased levels [39] [79].
Many publications state that the increase in n-6 fatty
acids resulted in a reciprocal decrease in n-3 fatty
acids [79]. However the data on fatty acid composition
36
is normally presented as a percentage of total fatty
acids, and the absolute amounts are rarely quoted. Only
a few have examined myocardial fatty acid composition
in phospholipid fractions ; PC, PE and CL. These
experiments identified PC and PE as being most
susceptible to dietary manipulations [80] [81]. There
are no reports on the composition of the two minor
phospholipid fractions; PI and PS.
The fatty acid composition of fish oil is
specifically rich in the (n-3) essential fatty acids
eicosapentaenoic (20:5(n-3;) and docosahexaenoic
(22:G(n-3)). After feeding diets supplemented with
extreme amounts of fish oil (up to 30% kcal energy from
fish oil) statistically significant alterations were
seen in the fatty acid composition of heart tissue
phospholipids [82] [83] [84], with an increase in (n-3)
fatty acids related to the amount of fish oil in the
diet. 20:5(h-3) is the fatty acid which shows the most
significant increase [85]. Linked to the increase in (n-
3) fatty acids is a decrease in (n-5) fatty acids,
specifically in arachidonic acid [86] [87]. The
mechanism causing the reduction in arachidonic acid is
not that of simple substitution and is discussed in
section 1.3.3. The PE phospholipid fraction has been
documented to be most susceptible to dietary fat
manipulation [88], but again no data is available on
the effects of fish oil diets on PI or PS.
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Diets enriched with saturated fatty acids have not
been as extensively studied. However some studies have
been carried out with diets supplemented with coconut
oil [89], palm oil [90] and sheep perirenal fat [91].
The results of such experiments are inconclusive, as
often there is no true control group to compare the
fatty acid compositions to. However, a trend towards
an increase in myocardial phospholipid saturated fatty
acid composition is observed. Experiments with diets
enriched in rapeseed oil, which is rich in the mono-
unsaturated fatty acid erucic acid (22:1 (n—9)) have
also been investigated [89] [92]. Such diets have been
found to increase the levels of 22:1(n-9) in the
myocardium phospholipid and cause myocardial necrosis
[93] [94].
The results show that a complex interaction exists
between dietary (n-3) and (n-6) fatty acids. This is
primarily the result of competition for the same elon¬
gation desaturation enzymes. Until a full understanding
of the control process in this system is known a true
understanding of the mechanisms and biological con¬
sequences of dietary fat manipulations will not be
fully achieved. Nonetheless the identification of an
alteration in myocardial function after dietary feeding
has driven many workers to investigate the functional
consequences of the changes described in myocardial
phospholipid fatty acid composition after feeding diets
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enriched in (n-3) and fn-6) fatty acids.
One of the major areas under investigation is the
interaction between membrane phospholipids and
proteins. The function of a specific protein can be
modulated by the lipid milieu in which it exists.
Several enzymes have been identified whose function can
be altered in-vitro by different fatty acids in the
phospholipid membrane [95] [96]. Studies have also
shown an effect on protein function after dietary
fatty acid manipulations and have [97] [98]. However a
full understanding of the implications of dietary fat
manipulations is still far from clear.
1.3.3 Fatty acids and prostanoids.
Prostanoids are a group of compounds with
remarkable pharmacological and physiological properties
derived from triene, -tetraene and -pentaene fatty
acids of which those based on arachidonic acid are the
most entensively studied. The specific fatty acid pre¬
cursor (20:3(n-6), 20:4(n-6) or 20:5(n-3)) determines
the particular series of prostanoid to be synthesised,
the 1-, 2- or 3- series. These precursors are obtained
directly from the diet or by elongation/desaturation of
essential polyunsaturated fatty acids present in
membrane phospholipids (Figure 1.5).
Prostanoids are not stored in mammalian tissue and
their release from organs is therefore indicative of de
novo synthesis. The type and proportion synthesised is
39
dependent on the situation, the tissue and the cond¬
itions at the time. Each series is synthesised via a
single pathway (Figure 1.7) which produces a variety of
prostanoids. The compounds have half lives of minutes
or less and are then metabolised rapidly to less active
compounds [99], This particular property has made the
study of these compounds difficult, with measurements
relying on the assay of stable metabolites. Recent
developments have improved analysis using in particular
the chemical stabilisation of the prostanoids on
collection [100].
Arachidonic acid is the most common prostanoid
precursor in the myocardium, with minimal synthesis of
the '11 and '3' series. The major metabolite released
from the isolated perfused rat heart (endothelial cells
plus myocytes) is prostacyclin, whereas platelets are
the major site of thromboxane production. In vitro
experiments have given conflicting results on prosta¬
cyclin production from isolated myocytes [101]. The
discrepancies appear to be related to possible contami¬
nation of the cell preparations with endothelial cells,
as recent experiments with improved techniques have
identified no production of prostacyclin from myocytes
in culture [102].
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Prostacyclin and thromboxane have opposing effects
on platelet aggregation, prostacyclin inhibits, whereas
thromboxane promotes action [103], Involvement of this
function has been proposed in the development of
thrombi and atherosclerotic plaques. The relative
balance between the two has been implicated in the
development of coronary heart disease and is the basis
from which the clinical thrombosis trials involving
aspirin developed.
Increased bleeding time in fish eating populations
[104] was proposed to be the result of a switch in
prostanoid production from the '2' to '3' series. How¬
ever, although there is some substitution the increased
time for platelet aggregation appears to predominantly
via the inhibition of the synthesis of the '2' series
by increased 22:6(n-3) in the diet [105]. Increases in
prostanoid production have been found between border¬
line EFA deficient diets and linoleic acid rich diets
[73]. No dose response effect has been observed with
increasing dietary linoleic acid, and if a 'mega' dose
is consumed prostanoid production is in fact inhibited
[48] .
Prostanoid involvement in arrhythmias has been
studied and has produced a large amount of conflicting
results [106], The reasons for such discrepancies are
probably differences in species, anaesthetic, vehicles
used for administration, doses and routes of
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administration. Furthermore, the short half-life of the
active compound makes pharmacological experimentation
difficult. Prostacyclin or its stable analogue iloprost
and PGE2 are antiarrhythmic in animal experiments using
occlusion of the left anterior descending coronary
artery as the experimental model [106] [107]. Prost¬
anoid inhibitors have also been used for investiga¬
tions, but again the results are contradictory, with an
effect appearing to intimately depend on the dose of
drug used. In general, indomethacin, iboprofen and
flurbiprofen have all been reported to exacerbate
arrhythmias at high doses, while reducing them at low
doses. In contrast aspirin appears to have an anti¬
arrhythmic effect at both high and low doses.
Prostanoids have been proposed to be the mechanism
whereby (n-6) and (n-3) fatty acids exert their essential¬
ity for normal cellular function. However, prostanoid
are formed in exceedingly small amounts in vivo and
would require to be turned over metabolically at an
impossibly high rate to account for the large dietary
requirement for (n-6) PUFA in mammals (in the region of
2-4% of the total calorific intake per day in man). In
conclusion, the highly active prostanoids appear to be
intimately involved with the development of arrhy¬
thmias, but the full implications of these actions have
still to be realised.
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1.4 Arrhythmias.
1.4.1 Experimental models for the study of
arrhythmias.
There are two approaches to the study of arrhy¬
thmias. One is to mimic the situation observed in man
and the other is to use substances which have been
found to induce arrhythmias.
The occurrence of an ischaemic episode is the
major cause of arrhythmias [108]. A large number of
different experimental models have been developed to
study the consequences of myocardial ischaemia. Before
discussing the differences among the various experimen¬
tal models, the biochemical and physiological con¬
sequences of ischaemia are briefly summarized.
Ischaemia is defined as a lack of blood supply to
a particular tissue. This results in a deficit of
oxygen, substrate and energy supply as well as reduced
removal of potentially toxic waste metabolites such as
lactate, carbondioxide and protons. The events respon¬
sible for the ischaemic event v/ere briefly discussed in
section 1.1. The onset of ischaemia results in a number
of deleterious changes which are summarized in Figure
1.8. The events depicted are not intended to occur in





Events occuring after the onset of
ischaemia.

















Disturbances of transmembrane ionic balance
Utilisation of dissolved oxygen
Reduction of mitochondrial activity and oxidative metabolism
Reduced ATP production
Reduction of creatine phosphate stores
Reduction of amplitude and duration of action potential
Leakage of potassium ST segment changes
Accumulation of sodium and chloride ions
Catecholamine release
Stimulation of adenyl cyclase
Stimulation of glycogenolysis
Net utilisation of high energy phosphates
Accumulation of protons, carbon dioxide and inorganic phosphate
Stimulation of phosphofructokinase activity
Increase of glycolytic flux
Development of intracellular acidosis
Reduction or blockage of mitochondrial electron transport
Repression of fatty acid oxidation
Utilisation of glycogen
Leakage of inorganic phosphate
Accumulation of NADH
Increased lactate dehydrogenase and a-glycerophosphate dehydrogenase activity
Accumulation and leakage of lactate
Accumulation of fatty acyl CoA derivatives
Depletion of creatine phosphate
Leakage of adenosine, inosine and other metabolites
Vasodilation
Inhibition of adenine nucleotide transferase activity
Possible stimulation of triglyceride synthesis and degradation
Increasing cellular acidosis
Repression of phosphofructokinase and glyceraldehyde-3-phosphate dehydrogenase activity
Slowing of glycolytic flux
Cell swelling
Increase in cytoplasmic ionised calcium content
Leakage of magnesium ions
Possible exhaustion of glycogen reserves
Inhibition of glycolysis
Severe reduction of ATP
Minor ultrastructural changes, for example mitochondrial swelling
Possible onset of contracture
ONSET OF IRREVERSIBLE DAMAGE?
Lysosomal changes and activation of hydrolases and lipoprotein lipases
Increasing cellular oedema
Loss of mitochondrial respiratory control
Non-specific electrocardiographic changes
Ultrastructural changes in mitochondria and myofibrils
Complete depletion of energy reserves
Loss of mitochondrial components
Leakage of enzymes to interstitial space and lymph
Severe ultrastructural damage and membrane deterioration
Disruption of mitochondria, myofibrils and cell membranes
CELL DEATH AND TISSUE NECROSIS
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Two types of ischaemia can be induced experiment¬
ally, global or regional. Clinically global ischaemia
(i.e. of the whole heart) is rare, but is observed
during cardiac surgical procedures, such as cardio¬
pulmonary bypass where the aorta is cross-clamped.
Regional ischaemia is assumed to mimic the clinical
sitiiation in patients with coronary heart disease. In
animals regional ischaemia is induced by temporary or
permanent occlusion of one or more healthy coronary
arteries (spontaneous atherosclerosis is rare in most
experimetal animal species). Two methods can be used to
occlude, stitching and tying coronary arteries or
insertion of an intracoronary electrode. The latter
method uses electrical stimulation to induce thrombus
formation and hence ischaemia. This method reproduces
the potentially gradual or intermittent development of
intracoronary thrombus found clinically in man. How¬
ever, limited control over the severity and onset of
ischaemia make it less useful to monitor the
suitability of various therapeutic interventions, and
is for obvious reasons not technically possible in
small animals. Therefore, although not an exact
replicate of the clinical situation stitching of the
coronary artery is the method most frequently chosen by
experimentalists to assess the viability of an anti¬
arrhythmic effect.
The choice of in-vivo or in-vitro conditions
46
depends on the purpose of one's proposed studies. In
the context of this thesis, the in-vitro Langendorff
was preferred. Earlier studies in-vivo suggested an
antiarrhythmic effect of diets enriched with linoleic
acid. Therefore the principal reason for the choice was
to confirm previous antiarrhythmic findings in-vitro
without the influence of circulating factors such as
platelets and removing some of the influences of the
intact nervous system. This method had the further
advantage of being reproducible and technically easier
to perform allowing the study of large numbers of
animals, thus increasing the statistical power of the
studies. Information on coronary flow and myocardial
metabolism are not obtainable from in vivo experiments
but are measurable in the in-vitro system. The effect
of drugs is directly on the heart and would not be
influenced by an effect on another organs or circula¬
ting factors in the intact animal. The one major dis¬
advantage of the method is that in the absence of blood
pressure measurement, (available in the in vivo model)
which aids identification of VF and VT which can be
difficult. This problem can be overcome by enforcing
the guidelines of the Lambeth Convention [109], The
convention states that "randomisation to treatment and
blind analysis are essential" to prevent biased anal¬
ysis. At the start of all experiments, the classifica¬
tion of VT and VF must be clearly defined (Figure 1.9).
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FIGURE 1.9 Examples of the classification of
arrhythmias.
VENTRICULAR TACHYCARDIA
RUN OF FOUR OR MORE CONSECUTIVE VENTRICULAR PREMATURE BEATS.
VENTRICULAR FIBRILLATION
A SIGNAL FOR WHICH INDIVIDUAL QRS DEFLECTIONS CAN NO LONGER BE
DISTINGUISHED FROM ONE ANOTHER AND FROM WHICH A RATE CAN NO
LONGER BE MEASURED.
The incidence of arrhythmias can be low in animal
models, even after ischaemia is induced. Therefore,
many experimentalists modify conditions to increase the
incidence on occlusion. Two methods are most commonly
used, the alteration of potassium levels [110], [111],
or the use of animals which are older [112]. The
incidence of ischaemic arrhythmias is well documented
to increase with age [113] [112]. Throughout this
thesis potassium levels in the perfusate were reduced
from the physiological concentration in the rat of 6.1
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mM to 3.0 mM [114]. Other experimentalists have
employed the use of diuretics which reduce plasma and
myocardial potassium levels or feeding diets low in
potassium, to animals prior to study [114] [115].
The use of compounds to induce arrhythmias is a
technique whose relevance to the clinical situation is
questionable. The compounds most frequently used in¬
clude ouabain [116], isoprenaline [117], CaC^ [118]
and arachidonic acid [119]. The compounds are injected
intravenously and the mechanism of 'sudden death' is
frequently unknown. Therefore, several factors may be
involved and the cause of death might be extracardiac.
Indeed, arachidonic acid was assumed to cause sudden
cardiac death, but in one study employing histo-
pathology lung embolism was subsequently found to be
the true cause of death [119]. Therefore, although
these methods are very simple, evidence of their mode
of action must be an absolute prerequisite.
1.4.2 Essential fatty acids and arrhythmias.
The first in vivo antiarrhythmic effect of lin-
oleic acid rich diets was reported by Szekeres et al in
1980 [39]. The feeding of standard chow supplemented
with 12% w/w sunflower oil to 12 week old male rats
resulted in a significant reduction in both VF and VT
when compared to the standard laboratory chow (5% fat).
The results did not discount any influence from reduced
mineral or vitamin intake as a result of an imbalance
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in calorific intake. The diets used were extreme, a P/S
ratio of 6.5 for the sunflower diet, which could not be
achieved by dietary modification of the average British
diet. Therefore the clinical relevance of these results
is questionable.
Other research groups have published the effects
of linoleic acid rich diets on the incidence of
ischaemic VF both prior and after Szekeres's
publication. An earlier experiment by Logan et al [118]
using CaCl2 to induce arrhythmias compared two semi¬
synthetic diets with 20% w/w safflower oil or beef
dripping and demonstrated no antiarrhythmic effect. The
incidence of VF after a feeding period of one month was
45% in the safflower oil group and 50% in the beef
dripping group (not significant). Linoleic acid levels
in myocardial triglycerides increased (5% to 44%),
however the results are only on the basis of one
analysis. The numbers reported were small (n=10 per
group) and insufficent to base any solid statistical
analysis with a control incidence of 50%.
An Australian group headed by Dr J Charnock has
published a great deal of work in this area in recent
years. In 1985 they published an antiarrhythmic effect
of linoleic acid rich diets [40]. The experimental
diets used were fat supplemented chow with both the fat
content and composition more realistic than Szekeres
(16% w/w fat and P/S ratios of 0.2 and 3.6). Standard
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laboratory chow (4% fat) was the control. The
difference in calorific intake resulted in an average
consumption of the diet in the oil supplemented groups
of 20gm/day as opposed to 23gm/day in the reference
group. Therefore the dietary mineral intake by the rats
differed. The vitamin E content of the diets were
uncontrolled, therefore an influence from this
potentially anti-arrhythmogenic factor [120] could not
be removed. The numbers of animals per group were very
small (n=5) therefore statistical conclusions should
not have been drawn. In this study in contrast to other
publications the length of time the animals were fed
diet was much longer, 7 and 20 months as opposed to 1
and 3 month feeding periods used by Logan and Szekeres.
More recent publications from this Australian group
have illustrated an antiarrhythmic effect during both
ischaemia and reperfusion with fish oil supplemented
diets [121]. However the same critisms on the use of
unbalanced diets and group sizes remain even with the
number of animals per group increased to ten.
One other group has recently published on the
effect of linoleic acid rich diets in the isolated
perfused working heart [72]. The diets used by this
group were purified and semi-liquid and extremely
unrealistic if extrapolated to man (P/S ratio of 5.3
(sunflower seed oil) and 0.001 (coconut oil). Further¬
more the diet rich in saturated fat (hydrogenated
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coconut oil) could have been EFA deficient. The number
of animals screened for arrhythmias was again small
(n=12). After 1 week of feeding these diets there was a
change in myocardial phospholipid fatty acid
compositions between the two groups. The perfusion
results were expressed as an overall arrhythmia score
(i.e. VPB's, VT and VF). There appeared to be a trend
towards a reduction in the incidence of VF in the
linoleic acid rich diet but, no statistical analysis
had been carried out, presumably because of the small
numbers.
The work described above indicates that linoleic
acid rich diets could be antiarrhythmic. However, there
are various shortcomings in all of the experiments.
Without exception, the experiments used too few
animals. None of the experimental diets correctly
controlled the vitamin and mineral contents. The
absence of an antiarrhythmic effect in Logans
experiments with equally small numbers could indicate
that linoleic acid is not antiarrhythmic if controlled
semi-synthetic diets are used.
As was mentioned the effect of fish oil diets on
ischaemic VF have also been studied by two other groups
and have given inconclusive results. The first study
was carried out in 1980 by Culp et al [122] in dogs.
The experimental diet used contained large amounts of
fish oil (25% Kcal) and was given over a period of 36-
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45 days to a group sizes of only 10. The control group
was given standard uncontrolled dog chow (no fat
supplement, therefore not isocalorific) for 1-7 days.
Intracoronary electrodes were used to induce acute
coronary thrombosis and subsequent arrhythmias, there¬
fore all the problems discussed in the previous section
could be levelled at this study, specifically as fish
oil is believed to have anti-thrombotic properties
[123]. The incidence of VF was not significantly
different between the two groups (control=29% and fish
oil=30%). However, a reduction in the mean frequency of
ectopic beats from 80% in the control group to 30% in
the fish oil group was reported. The reduction was
assumed to be due to a reduction in infarct size (3^1
vs 25 _+ 4%). However, the proportion of the left ven¬
tricle deprived of blood was smaller in the fish oil
group (no data presented). This difference in myocar¬
dium at risk therefore acts as a confounder in the
experiment, and the control group with the greater
occluded zone would automatically have been expected to
be more succeptible to VF [124].
The other report was from Holland by Hartog et al
in 1986 [125]. This experiment investigated the effect
of fish oil diets on ischaemic arrhythmias in piglets.
The diets employed were identical in every factor bar
their fatty acid composition and subsequent P/S
ratio's. Like all the others large amounts of fish oil
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(23.9 kcal), which could never be consumed in man were
used. The results presented for VF were the result of
six 5-minute periods of ischaemia, induced by clamping
the left anterior descending coronary artery, followed
by a 10 minute period of reperfusion. No significant
differences were seen between the two groups. However,
it should be noted that the group sizes were very small
(n=8) and that reperfusion and ischaemic VF were not
distinguished (even though the mechanism of the two are
probably different).
In conclusion, the effect of linoleic acid and
fish oil on the incidence of ischaemic arrhythmias has
not been studied effectively. Isocalorific semi¬
synthetic diets and the use of the Langendorff model
with carefully controlled K+ would allow the study of
larger numbers of animals and remove the short comings
of previous experiments. In addition the possible
mechanisms responsible for the anti arrhythmic effect
could be narrowed down by removing the influence of
circulating factors (platelets,lipids, etc) present in
the in vivo model.
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HYPOTHESIS
Diets enriched in essential fatty acids reduce the
incidence of ventricular fibrillation during acute
myocardial ischaemia by altering the fatty acid





2.1. - Animal housing conditions.
Male rats were used throughout and the choice of
strain is discussed in Chapter 3. Four animals were
kept per cage and all animals for an experiment were
housed in one room. The ambient temperature was 20-21°C
and the light/dark cycle was a constant 12 hours on and
12 hours off. Water and food were given ad libitum. The
animals food and cages were changed three times a week
and body weights taken once a week.
2.2. - Diets.
2.2.1 Diet calculation.
All diets used were semi-synthetic. Every diet
was formulated from maize starch, casein, cellulose,
salt mixture, vitamin mixture and experimental fat (the
sources of which are presented in Table 2.1). The
amounts of fat, protein, carbohydrate, salts and vit¬
amins were calculated from Unilever Research food
tables [126].
The basic diet used in all experiments had 40%
energy from fat, 23% energy from protein and 37% energy
from carbohydrate. Table 2.1 shows the basic ingred¬
ients for a 40% energy fat diet. When different energy
percentages of fat were required the contribution of
carbohydrate was modified proportionately.
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TABLE 2.1 - Ingredients of a semi-synthetic rat diet
(40% energy fat).








Vitamin mix* Various (see appendix 1) 0.43
Salt mixture Various (see appendix 2) 2.33
Fat mixture Various (see appendix 3) 18.5
* N.B. minus vitamin E
In the initial studies Sigma vitamin free
casein (cat No.C3400) was used, but the high cost (£50
per 5kg) necessitated a cheaper source to be ident¬
ified. The effect of the cheaper milk marketing board
casein (Scottish Pride) on the incidence of VF was
examined using the methods stated in section 2.4. The
source of casein did not affect the incidence of VF
(Table 2.2).
TABLE 2.2. - The effect of M.M.B. casein on the
incidence of VF during acute myocardial ischaemia in
isolated perfused Lew rat hearts
Supplier % VF %VT
Sigma (n=36) 53 97
M.M.B. (n=32) 56 97
(N.S. after Chi-square test)
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The required fatty acid composition of the exper¬
imental fat was obtained by mixing edible oils. The
precise mixture was calculated using a computer program
solving simultaneous equations (LPGO ; Mr R H Fawcett,
Agricultural Resource Management, Edinburgh Univ¬
ersity). The amount of saturated, monounsaturated and
polyunsaturated fatty acids of various oils and fats
were obtained by GLC analysis and/or published food
tables [127], The program calculated the optimal, most
economic fat mixture from the data of the available
oils. The fatty acid composition of the optimal
solution was checked gas chromatographically using the
methods stated in section 2.3.6 and 2.3.7.
Vitamin E deficiency has been linked to
arrhythmias [120]. Oils rich in polyunsaturated fatty
acids are also rich in vitamin E. Therefore, to prevent
any confounding influence a constant vitamin E level
was calculated for each experiment. The amounts were
either adjusted to the highest level in a particular
experiment or to the minimum requirement of 80 IU/kg
diet [128] by the addition of d-a-tocopherol acetate
(see each experiment for specific values).
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2.2.2 Diet Preparation.
All diets were prepared in a specially designed
diet kitchen.
Three types of balance were used throughout to
weigh differing quantities of ingredients:-
(1) for weights less than 1g the Oertling balance was
used.
(2) for weights between 1g and 100g the Sauter RL200
was used.
(3) for weights greater than 1OOg the Sauter Shandon
Tara was used.
The salt mix was made using the ingredients listed
in Appendix 2. The salts were mixed 1-2 minutes in the
Robot Coupe and then aliquoted in 46g batches (suff¬
icient for 2kg of complete diet) into sealed plastic
containers and stored in the diet kitchen. The vitamins
listed in Appendix 1 were weighed and mixed for less
than 1 minute in the Robot Coupe, aliquoted into 8g
batches (sufficient for 2kg of complete diet) and
stored in sealed plastic bottles in the cold room.
All the dry ingredients (i.e. cornflour,
cellulose and casein) were preweighed and stored
together in batches required for 2kg of diet in plastic
bins in the diet kitchen.
The fat mixes were prepared freshly each day in
2kg batches. The solid fats were melted, then
tocopherol acetate (vitamin E) and the other oils were
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added then mixed thoroughly. The fat handling and sub¬
sequent mixing was initally a slow process, involving
melting the solid fats in a water bath at 50°C. In
March 1988 a microwave oven was purchased. This melted
the fat much more efficiently at a power setting of 9
for 3 minutes, with the temperature not increasing
above 50°C. All fats were stored in the 4°C cold room.
All pre-prepared ingredients were mixed using a
Robot Coupe. A maximum of 2kg was mixed at any one
time. The dry ingredients plus salt and vitamin mix
were mixed together for less than 1 minute in the Robot
Coupe mixer. The mixer was switched on at low speed and
the weighed, molten fat mix was slowly added. The
complete mixture was mixed for 2 minutes at low speed
and then 1 minute a high speed. The mixer was then
emptied and the diet stored in the cold room. The
process was repeated until sufficient diet had been
made. The mixer was thoroughly washed after every dif¬
ferent diet.
To minimise peroxidation, diet was freshly pre¬
pared every week and stored in containers under argon
in a cold room (4°C). To further limit peroxidation of
fresh diet was fed and cages changed every second day .
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2.3 - Biochemical Measurements.
2.3.1 Lactate Measurement.
Lactate was measured in perfusion fluid less than
60 minutes after collection using a fully enzymic kit
produced by Boeringer Mannheim (kit No. 256773).
The principle was a coupled assay and is shown by
the following reactions:-
L-Lactate + NAD+ Pyruvate + NADH + H+
Pyruvate + L-glutamate GpT L-alanine + 7-oxoglutarate
Lactate was measured spectrophotometrically
(350nm ; 37°C) as NADH produced in the conversion of
lactate to pyruvate in the presence of excess NAD+. The
equilibrium of the second reaction lies far to the
right and drives the complete conversion of the first
reaction.
The reagents used were as stated in the kit except
a 60% lower NAD+ concentration was used, as the kit was
designed for clinical samples with a much greater con¬
centration of lactate. The standard used was a trip¬
licate measurement of 1mM L-lactate.
A Cobas Bio centrifugal analyser (Roche Diagnos¬
tics) was used for all the measurements. To allow
comparisons both between and within studies Precinorm S
(Boeringer) was used as a quality conrol (nominal mean
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concentration 88O11M/L). The inter assay coefficent of
variation of lactate was determined by repeated
analysis of Precinorm S throughout all the studies
(Table 2.3). Two values are given for inter assay
because the batch of quality control was changed one
year into the study. Lactate is expressed as
uM produced / minute / gram wet weight of heart
throughout.
TABLE 2.3 - Coefficients of variation of lactate.
Coefficient of Variation
Intra assay 0.879 %
Inter assay (within study) 6.4 %
Inter assay (between studies)
1/10/86 - 1/11/87 3.0 %
2/11/87 - 31/9/89 10.1 %
2.3.2 Lactate dehydrogenase (LDH) measurement.
LDH activity was measured using the optimised
standard method produced by Boehringer Mannheim (kit
No. 543039). The principle of the measurement was the
following forward reaction:
Pyruvate + NADH + H+ ~*T L-Lactate + NAD+LJJn
Therefore, LDH was measured spectrophotometrically at
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340nm ; 37°C by the disappearance of NADH. All
solutions were as described in the kit. The activity
was measured on a Cobas Bio centrifugal analyser and
the results were calculated from the change in optical
density. LDH has been documented to be unstable in
perfusion fluid, so its stability was monitored over a
period of 2 hours (Figure 2.1.). The results showed
that all samples were stable up to 2 hours after colle¬
ction whether stored at 4UC or room temperature. All
samples were stored at 4°C and measured within 2 hours
of collection throughout the study.
Intra and inter assay quality controls were mon¬
itored using Precipath UBS (Boeringer ; mean concen¬
tration 445 U/l). The coefficents of variation were
determined by repeated analysis of Precipath UBS
throughout all the studies (Table 2.8)
The results are expressed in Units/minute/gram
wet weight heart throughout.
TABLE 2.8 - Coefficient of variation for LDH
measurement.
Coefficient of Variation
Intra assay 3.1 %
Inter assay (within study) 7.5 %
Inter assay (between studies) 10.4 %
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FIGURE 2.1. - Stability of LDH in perfusion fluid over
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2.3.3 Analysis of total and fractionated myocardial
phospholipids.
Total and fractionated phospholipid analyses were
carried out in batches of eight hearts plus a blank
(the hearts were randomly selected).
Hearts were freeze dried for 48 hours on an
Edwards Modulyo freeze drier. Each heart was crushed
into a fine powder using a mortar and pestle. The
powder (less than or equal to 145mg ) was weighed and
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transferred into Quickfit tubes (20 x 125 mm).
The phospholipids were extracted according to the
method of Folch [129] using 21 ml chloroform/methanol
(2:1 v/v). The lipid extract was dried down under
vacuum in a 1 1 Buchi flask using a Buchi-R rotary-
evaporator and a water bath at 30°C. The lipid extract
was redissolved in 2 ml methanol and 4 ml chloroform
and placed in a Quickfit tube. The extract was dried
down under vacuum and redissolved in 1.0 ml of
chloroform/methanol (2:1 v/v) using a Hamilton syringe.
Phospholipids were separated by T.L.C. using LK5
plates with a preadsorptive area (Whatman catalogue no.
4855 820 (20 x 20 cm)). The plates were impregnated
with 1.2 % boric acid and reactivated at 100° (60 min ;
[130]. One plate was used per sample to separate both
total and fractionated phospholipids. One hundred micro
litres of extract was spotted for total phospholipid
and a 100 ul was streaked across the remainder of the
plate for fractionated phospholipids (Figure 2.2). The
plates were developed in CHCl^ : MEOH : ^0 : NH^
(120:75:6:2 v/v/v/v) in a paperlined tank at room tem¬
perature. The plates were left to run for ~ 1 hour, air
dried and sprayed with 0.1% dichlorofluorescein. This
allowed the phospholipids to be visualised under ultra¬
violet light at 365 nm. A typical separation is shown
in Figure 2.2.
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FIGURE 2.2 Separation of myocardial total and
fractionated phospholipids.
All 5 bands were scrapped for total phospholipid
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The position of the bands using this particular
separation system had been previously identified using
known standards. The bands for total phospholipid and
each of the 5 fractions were scraped off and placed
into individual Quickfit tubes.
Before transmethylation internal standard was
added to every tube (the standard could not be added
earlier as specific standards for each phospholipid
fraction are not commercially available). The concen¬
tration of the standard depended on the particular
phospholipid fraction in the tube :-
a. For total phospholipid , PE , PC and CL 70ug phos¬
phatidylcholine C17:0 was added.
b. For PI and PS 2ug Phosphatidylcholine C17:0 was
added.
Base-catalysed transmethylation was carried
out as described by Christie [131] using toluene and
sodium methoxide (0.5M).
The methylesters were redissolved in 25ul
chloroform with 0.01% BHT and stored in GLC vials at
-20°C prior to GLC analysis. The results are expressed
as ug fatty acid /gram wet weight of ventricular heart
tissue.
2.3.4 Analysis of myocardial triglyceride fatty acids.
Triglyceride fatty acid analysis was organised as
for phospholipid fatty acid analysis in section 2.3.3.
Hearts were extracted as in section 2.3.3. One
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fifth of the final lipid extract (200 ul) was trans¬
ferred to a Quickfit tube and 40 ug of internal stan¬
dard (triheptadecanoin) was added . The lipid fraction
was dried down and redissolved in 1.0 ml of
chloroformrmethanol (2:1 v/v).
200 ul of lipid extract was spotted on Merck 5721
plates in 5cm bands. The plates were predeveloped in
hexane:diethylether:formic acid (80:20:2 v/v/v) for -45
minutes. The plates were air dried and sprayed with
POPOP/PPO to allow identification under ultraviolet
light at 365 nm. Figure 2.3 shows a typical separation.
The triglyceride band, previously identified using
known standards and was scraped off and placed in a
Quickfit tube.
Transmethylation was carried out as in section
2.3.3. The methyl esters were redissolved in 25 ul
chloroform with 0.01% BHT and stored at -20°C prior GLC
analysis. The results are expressed as ug fatty acid
per gram wet weight of ventricular heart tissue.
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1 = total phospholipid
2 = triglyceride
3 = cholesterol esters
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2.3.5 Analysis of adipose tissue fatty acids.
One experiment contained a maximum of forty sam¬
ples including a blank and a control.
Approximately 10 mg of adipose tissue from the
inguinal region of the rat was homogenised in all-glass
Elvjehem Potters using 5 ml isopropanol/heptane (4:1
v/v). Phospholipids and free fatty acids were back
extracted using 3ml KOH (0.05 %) and the triglyceride
remained in the top organic phase. This was then washed
with 8 ml of isopropanol/KOH (0.05% ; previously washed
in heptane (4:1:3 v/v/v)). The heptane layer was tran¬
sferred and evaporated to dryness using the Buchi (see
section 2.3.3).
Transmethylation was carried out as in section
2.3.3. The methyl esters were redissolved in 40 ul of
chloroform with 0.01 % BHT and stored as in section
2.3.3.
The results were expressed as a percentage of the
total weight of the fatty acids. Calculation of the
coefficient of variation was determined by repeated
analysis of a single large sample of human adipose
tissue. An aliquot was analysed with every study, which
gave a coefficent of variation for 18:2(n-6) of 1.8%,
which allowed interstudy comparisons.
2.3.6 Fatty acid analysis of oils and diets.
Lipids were extracted from approximately 80 mg of
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oil or 150 mg of diet. The particular sample was
weighed out and the lipid was extracted in 240 ml of
chloroform:methanol (2:1 v/v). 15 ml of the resulting
extract was then transferred to a Quickfit tube.
An internal standard of triheptadecanoin (1mg/ml)
was added to the Quickfit tube. 4 ml KCL (0.88 %) was
then added to remove contaminants such as protein and
glycerol. The solution was then shaken, and spun in a
IEC Centra-7R centrifuge at 400 G at 20°C for 5
minutes. The lipid phase was transferred to a Quickfit
tube and evaporated to dryness using a Buchi rotary
evaporator and a water bath at 30°C.
Transmethylation was carried out as in section
2.3.3. The methyl esters were redissolved in 200ul
chloroform with 0.01 % BHT and stored as in section
2.3.3. The coefficent of variation for this method was
determined by repeated analysis of one diet (n=12 ; 40%
energy fat, P/S 0.3) and a value of 1.96 % was cal¬
culated for 18:2(n-6).
2.3.7 Gas liquid chromatography.
The GLC system used was a Pye Unicam Series 204
gas chromatograph fitted with a PU4700 autoinjector and
linked to a Trilab Model II integrator (Trivector). A
glass column (1.5 m long , I.D. 2 mm) packed with a
stationary phase of 10% SP2330 on 100/120 mesh
Chromosorb WHV7 (Supelco) was used for all separations.
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The following parameters were used :
injector temperature - 220°C
detector temperature - 300°C
column temperature - 180°C
hydrogen gas flow - 50 ml/min
carrier gas flow - 50 ml/min
air flow - 550 ml/min
Temperature programme inital minutes - 3
rate °C/min - 3
final temp - 250°C
final minutes - 5
All fatty acids methyl ester peaks had been pre¬
viously identified using authentic materials
(Sigma standards ; 20:3(n-9) from Dr. EAM de Deckere,
Unilever Research, Vlaardingen, The Netherlands and/or
argentation chromatography (courtesy of Karin Lyall
Cardiovascular Research Unit, Edinburgh)). The relative
retention times with respect to C17:0 methyl esters
were used thereafter.
Solutions of methyl esters stored in the freezer
were equilibrated to room temperature before being
placed on the autoinjector. Methyl esters from samples
of PI and PS (5 ul) were injected on to the column
using a 10 ul syringe, all other methyl ester samples
were injected (1 ul) using a 1 ul syringe.
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All results were stored on the Trilab system.
After inital visual inspection for correct separation,
identification and baseline tracking the samples were
re-analysed where neccessary. All results were then
transferred to a BBC computer disc and statistical
analysis was carried out as described in section 2.5.
2.3.8 Prostacyclin measurement.
Prostacyclin was measured as its metabolite
6-oxo-F^a using a radioimmunoassay involving a novel
iodinated label and magnetic separation as described by
Kelly [100]. Like all basic immunoassay systems this
method has 4 major components; the labelled antigen,
the antibody, the separation system and the unlabelled
antigen (the sample). This method is novel v/ith respect
to the production of the labelled antigen and the
separation system employed (Figure 2.4)
The labelled antigen was produced in response to
an injection of methyloximated 6-oxo F^. Methyl-
oximation ensures production of a high sensitivity
antiserum because endogenous ligands are unable to
saturate the reaction. Furthermore, the required methy-
loximation of all samples confers stability during
storage and throughout the assay proceedure. The
125
antigen is then coupled to I label through an imide
linkage rather than the conventional amide linkage thus
confering further sensitivity.
74
FIGURE 2.4 - Amerlex
Polymore bead coated with second Ab
Magnetizable component
Each assay tube contains sev
million particles in sus¬
pension. The Amerlex-M
second Ab binds the primary —
Ab and hence permits separ¬





After incubation, the assay
tube is placed in contact with
a magnetic base. The superna¬
tant is decanted leaving dense
pellet.
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The use of Amerlex (Figure 2.4) reduces the time per
assay as it combines antibody addition and separation
to a single step.
The label, standards and antisera were all
obtained from Dr Kelly (Centre for Reproductive
Biology, Edinburgh). Amerlex (cat no. RPN 510) and
magnetic packs were purchased from Amersham and all
other chemicals from Sigma.
All samples were collected and stored according to
the method described by Kelly [132]. The perfusate
samples were assayed as described for PGE2 measurement
of tissue samples in the paper by Kelly et al [100].
All samples were measured in duplicate and quality
control was prepared (perfusate plus standard) which
gave an interassay coefficent of variation of 12 %. All
results were expressed in ng / minute / gram wet weight
of heart tissue.
2.3.9 Radioenzymatic measurement of noradrenaline.
Noradrenaline concentration in perfusate was
measured radioenzymatically by Margaret Millar (Cardio¬
vascular Research Unit, Edinburgh).
Noradrenaline was converted to its 3-0-methylated
derivative using catechol-O-methyl transferase (COMT)
3
in the presence of a radioactive methyl donor, H -
methyl-5-adenosyl methionine ("^H-SAM ; Figure 2.5).
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FIGURE 2.5 Reaction involved in the radioenzymatic
measurement of noradrenaline.
The product (normetanephrine) was purified by
selective ion pair extraction with tetraphenylborate,
separated by TLC and subsequently oxidised to vanillin.
The final product was counted in a liquid scintillation
counter.
All chemicals were obtained from BDH and the stan¬
dards were ordered from Sigma. The COMT was prepared as
described by Da Prada and Zurcher [132] and was stable
for at least three months when stored at -20°C.
500 ul of perfusate, collected on reperfusion was
immediately placed in a Beckman Tube with 500 ul of
0.6N perchloric acid and stored in the -40°C freezer
until assayed. The procedure for plasma samples as
stated by Da Prada [132] was followed, except that the
concentration of standards used was 60 and 600
fmole/tube. The coefficent of variation was calculated
from the repeated analysis of the standards in one of
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the experiments and gave a value of 12.4 % for the
highest standard (600 fmol/tube) and 52.7 % for the
lowest standard (6 fmol/tube).
All results are presented as pmol produced/gram
wet weight heart tissue/minute.
2.4 - Langendorff perfusion.
2.4.1 Procedure.
The perfusion system adapted from Langendorff
[134] was used (Figure 2.6). A modified Ringer-Locke
solution (perfusate) was freshly prepared using double
distilled water for each experiment. The ionic con¬
centrations are shown in Table 2.6. The energy sub¬
strate used was glucose (5.5mM). The perfusate was
maintained at 37°C and gassed continuously with 95% ,
5% CC>2 (2 1/min). Typical pCC^, pC>2 and pH values are
shown in Table 2.6.
Rats were anaesthetised with Sodium Pentobarbitone
(60 ug/g body weight) by intraperitoneal injection.
Heparin (0.25 units/g body weight) was injected into
the femoral vein, a minimum of 30 seconds prior to the
removal of the heart (this ensured an adequate
distribution throughout the blood pool). The heart was
then excised rapidly and placed in ice cold perfusate.
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TABLE 2.6 - Ionic concentrations in the 'Perfusate'
Ion Concentration
K+ 3. OmM
Ca2 + 2. 5mM
Na + 1 41mM
Cl~ 1 2 6mM






The aorta was located and the heart was attached
to the cannula using a 2/0 Mersilk thread (Figure 2.7).
Four hearts were mounted per experiment (Figure 2.6). A
ligature (Mersilk 4/0 16 mm suture) was placed around
the left anterior descending coronary artery of each
heart. Portex non-sterile polythene tubing (I.D. 0.86
mm ref 800/110/260/100) was then threaded through
(Figure 2.7). This allowed occlusion and reperfusion of
the coronary artery in each heart. Two silver ECG
electrodes were then attached to each heart, one to the
right atrium and the other to the anterior wall of the
apex. The hearts were then left to stabilise for 5
minutes.
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Occlusion of the artery was achieved by pulling
the suture threads through the tube and securing them
by clamping the tube with a staple (Figure 2.7).
The electrocardiograms were recorded continuously
on a Gould TA 2000 recorder with a paper speed of 2.5
cm/s. After 20 minutes the Portex tubing was cut,
thereby releasing the occlusion without damaging the
heart. After 5 further minutes of reperfusion the
experiment was completed. The hearts were removed,
atria trimmed and then weighed and stored for possible
analysis.
2.4.2 Protocol.
A basic protocol for each perfusion experiment
was applied. All arrhythmias were screened using the
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Langendorff perfused isolated male rat heart model
(Figure 2.6). The hearts were all studied when the
animals were 1 6 weeks of age without prior knowledge of
their dietary status. All experiments were designed
with a contemporary control group. The group size was
calculated using the required statistical equation (see
Section 2.5.1) as stated in the Lambeth convention
[109]. The presence of arrhythmias was monitored for
20 minutes of ischaemia and during 5 minutes of
reperfusion. Figure 2.8 shows the measurements which
were taken in each experiment to monitor the degree of
occlusion and subsequent ischaemia. Coronary flow was
calculated by weighing the amount of perfusate
collected from the heart over a 30 second time inter¬
val. The methods for all the other measurements are
described in section 2.3.
Adipose tissue samples were taken for triglyceride
fatty acid analysis from the inguinal region of each
rat from every fourth run (1 run = 1 complete
experiment as in Figure 2.8). The ventricles of the
hearts from every fourth run were stored in liquid ^
for phospholipid fatty acid analysis.
The electrocardiograms were analysed 'blindly' for
the arrhythmia parameters VF, VT and ectopic beats,
classified as stated in the Lambeth Convention [109]




























The heart rate was monitored pre-occlusion, 5 and
10 minutes after occlusion, but not at 15 or 20 minutes
because the presence of arrhythmias over this time
period made measurement inaccurate.
Results for a particular heart were excluded if
there were irregularities in the pre-occlusion electro¬
cardiogram and if two or more of the following criteria
occured:
(1) coronary flow reduction was less than 30 %
(2) initial lactate concentration was greater than 1
uMoles produced/min/g wet weight of heart.
(3) reperfusion lactate concentration was less than 1
uMoles produced/min/g wet weight of heart.
(4) LDH concentration was less than 0.5Units/min/g wet
weight of heart.
All the remaining results were then analysed using
the statistical methods described in the next section.
2.5 - Statisitical analysis.
All statistical tests were carried out using the
Minitab statistics package. To ensure non-bias
analysis, a statistical protocol for each parameter was
defined before the start of all experimental analyses.
The tests used and the parameters they were applied to
are described in the following sections.
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2.5.1 Design of experiment.
The group size for experiments necessary to demon¬
strate a 50 % reduction in the incidence of VF (p<0.05)
was calculated using the 'sample size' equation for
unequal groups [135], using the incidence of the con¬
trol group to define the 'normal' population (Chapter 3
discusses this topic further).
2.5.2 Statistical protocol for results from perfusion
experiments.
All biochemical measurements were normally distri¬
buted and the statistical protocol was one-way analysis
of variance of all the data. Follow up analysis was
carried out using an unpaired t-test on the parameters
which were significantly different (p < 0.05).
Arrhythmia incidences are classed as frequencies
and were therefore analysed using the chi-square test.
An overall chisquared test was applied and if a sig¬
nificance p < 0.05 was reached, then individual chi-
square tests were carried out to examine which groups
differed.
The other arrhythmia parameters such as onset and
duration had skewed distributions and were analysed
using a non-parametric test (Mann Whitney). Values
p < 0.05 were accepted as significant.
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2.5.3 Statistical protocol for the analysis of fatty-
acid results.
All results were analysed using an identical
protocol for a normally distributed population, as
described by other experimentalists [136] [82]. Fatty
acid composition, expressed as a percentage of the
total weight, can represent problems due to the inter¬
dependence of the relative amounts of the individual
fatty acids. All results for myocardial fatty acids
were therefore expressed as absolute amounts. Adipose
tissue was still expressed as a percentage of the total
fatty acids because it was only used as a general
indicator of diet. One-way analysis of variance was
carried out on all the fatty acid data from each
experiment, following which an unpaired t-test was
applied to the parameters which were statistically
significant to determine which groups differed. To
assess the biological importance of these changes with
respect to VF, correlations were made between the
incidence of VF and the mean value of any fatty acids
which were statistically significantly different.
2.5.4 Miscellaneous.
All other parameters were analysed using one way
analysis of variance followed by an unpaired t-test
when p<0.05 was reached.








The validity of all experiments depend on their
experimental design. The use of contemporary controls
throughout the course of the thesis was necessary as
there was no previous information on the incidence of
VF in animals fed semi-synthetic diets. This chapter
deals with some of the statistical considerations
required when testing an antiarrhythmic effect. The
occurence of serious ventricular arrhythmias is of
undisputed clinical importance, but it is a weak
statistical end-point. Often experimental studies give
little thought to the group sizes required to test an
antiarrhythmic effect. The numbers can sometimes be too
small and it is not uncommon for results of anti¬
arrhythmic interventions to be published on group sizes
of 10 or less [40] [118] [125]. In contrast to lab¬
oratory experiments, these problems are well recognised
in clinical trials and can be overcome by the calcula¬
tion of the correct group size.
The correct group size can only be calculated
apriori if the expected incidence of arrhythmias in the
population (ie controls) is known. Many experiment¬
alists do not know the expected incidence and cannot,
therefore, define the necessary group sizes. The min¬
imum group size required to demonstrate a specific
change in the incidence of VF can be derived from
Maisland contingency tables [137] (Figure 3.1) or from
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the 'group size' equation [135] (Figure 3.2), depending
on the particular requirements.
FIGURE 3.2 - Equation to calculate 'sample size'
assuming final populations could be unequal.
Sample number per group = k ( var^ + va^)
var^ = 100 - incidence in group 1 (%)
var2 = ^- incidence in group 2 (%)
D = difference to be detected
k = constant which depends on the significance level
and power required ( e.g. 1% or 5%)
Previous work carried out by Riemersma and Saman
[41] showed an incidence of VF during coronary ligation
in the isolated perfused heart from Sprague Dawley
rats fed 'control' diet (see section 3.2) to be 30%.
Assuming a 50% reduction in the incidence of VF to be
clinically relevant then the minimum group size
required for an experiment to show this effect with a
power of 90% at a 5% level of significance (using the
equation in Figure 3.2) was 80. These very large
numbers imposed limitations on the number of exper¬
iments which could be completed due to time and money.
If the basal incidence of VF was greater, then the
group sizes would be smaller.
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FIGURE 3.1 Minimum Group Requirements to document a
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GROUP SIZE .
Ordinate indicates detectable percentage
reduction from control, for a given group of equal
size at a significance level of p<0.05.
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Therefore, the aim of this first experiment was to
screen inbred rats to isolate a strain which had a high
incidence of VF under standard experimental and dietary
conditions. Inbred rats were chosen to reduce the
genetic variation expected with an outbred population.
Adipose tissue biopsies were taken to monitor the
animal's dietary intake. Heart tissue samples were also
taken to study the possible involvement of changes in
myocardial phospholipid fatty acids with the incidence
of ischaemic VF.
3.2 - Methods.
7 inbred strains of rat were selected on the basis
of availability and cost (Table 3.1). The outbred
Sprague Dawley Rat was selected as a positive control
as its incidence of VF on "control" diet had been
studied previously [41].
The 'control' diet chosen for all the studies, was
the diet consumed by the average Scottish male : 40%
energy fat with a P/S ratio of 0.3 [62]. This diet was
chosen as one of the major aims of this thesis was to
examine the effects of diets which could be consumed by
the average man on experimental animals.
The diet was calculated and made as described in
section 2.2 (ingredients listed in Appendix 3).
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TARLE 3.1 - Inbred strains of rat.
Strain Supplier
Hunter MRC Unit, Edinburgh University
Hypertensive MRC Unit, Edinburgh University
Obese Rowett Institute, Aberdeen




F344 Harlan Olac, Oxon
Lew Harlan Olac, Oxon
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15 male rats from each strain were placed on the
"control" diet at 8 weeks of age. The animals were
housed and cared for as section 2.1. After 8 weeks of
feeding they were anaesthetised, the hearts isolated
and screened for their incidence of VF during acute
experimental ischaemia using the standard methods and
protocol described in section 2.4. Adipose and heart
tissue were taken and analysed as described in section




There were marked statistically significant diff¬
erences in the incidence of VF between the strains
(p<0.01 ; Figure 3.3). Lew rats had the highest
incidence and therefore this strain was chosen for
future experiments. The obese strain of rat was omitted
from all the following results because of the high
incidence of preocclusion arrhythmias in all but 3
animals, the final number being too small to use in any
statistical comparisons.
The incidence of VT was much higher than that of
VF and, although a similar trend as seen with VF was
observed (Figure 3.3), statistical significance was not
reached (Figure 3.4).
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FIGURE 3-3 - Incidence of VF during acute coronary
ligation in isolated perfused hearts from different
inbred strains of rat.
0
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*p<0.01 (Chi-square test)
FIGURE 3.4 - Incidence of VT during acute coronary
ligation in isolated perfused hearts from different
inbred strains of rat.
N.S. after Chi-square test
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There was a trend towards an earlier onset and a
longer duration of VF with increasing incidence of VF
(Table 3.2); however these results were not statistic¬
ally significant.
TABLE 3.2 - Time to onset and duration of VF during
acute coronary artery ligation in isolated hearts of
inbred strains of rat.
Strain Onset VF Duration VF
(minutes) (minutes)
WKY 1 0.52 (7.00) 2.96 (3.97)
HYPERTENSIVE 12.91 (3.42) 3.57 (1.93)
HUNTER 13.16 (6.36) 2.51 (2.94)
F344 9.57 (1.81) 3.38 (4.34)
SHR 10.17 (2.55) 3.99 (4.92)
LEW 9.39 (3.74) 3.76 (5.77)
All values are mean _+ S.D . ; N.S . (Mann-Whitney test).
Reperfusion VF as distinct from ischaemic VF was
not different between the strains, with an average
incidence of 90% (not shown).
The results in Figure 3.3 and 3.4 were not due to
variations in the ischaemic zone, as the absolute and
relative reduction in coronary flow were not signif-
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icantly different between the strains.
3.3.2 Myocardial phospholipid levels.
Total phospholipid, PC, PE and PS levels did not
differ between the strains (Table 3.3). The amount of
fatty acids present as PI and CL phospholipid classes
did, however, differ between the strains (Table 3.3).
An inverse relation was observed between the myocardial
PI level and the incidence of VF in the inbred strains
(r=-0.920 ; Fig 3.5). There was a difference in CL
levels between the various strains. However, this dif¬
ference did not correlate with the incidence of VF,
although it was higher in the hypertensive animals
possibly reflecting an increased density of
mitochondria in these animals.
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TABLE 3.3 - Total and individual phospholipid Levels
(ug fatty acid/g wet weight) in hearts from inbred rats
Phospholipid Inbred Strain
WKY HYPER HUNTER F344 SHR LEW
TPL 10620 9854 9771 10168 9704 9800
(820) (767) (1155) (780) (188) (852)
PI 545#° 510 471 496 404# 420°
(58) (66) (77) (55) (79) (104)
PS 236 204 322 202 312 249
(53) (41) (86) (38) (84) (111)
PC 4991 4982 4918 4689 4711 4754
(445) (603) (963) (754) (441) (493)
PE 3862 3519 3535 3607 3423 3237
(278) (232) (431) (384) (478) (804)
CL 2022"1"/ 1 961 1 640 1 688*+ 1 750 1 688$^
(253) (172) (342) (190) (201) (230)
Identical symbols indicate statistical significance
between the 2 groups in the horizontal plane ; p<0.05.
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FIGURE 3.5 Correlation between the amount of fatty
acids in PI and the incidence of VF.
H.g fatty acid In Pi/g wt weight hea/t
3.3.3 Myocardial phospholipid fatty acid composition
The absolute amounts of the 17 individual fatty
acids of the 5 phospholipid fractions showed numerous
differences. In order to assess the possible physiolo¬
gical importance of such differences with respect to
the development of VF further statistical analysis was
carried out. The fatty acids of the individual phospho¬
lipid classes which were significantly different
between the 6 strains were related with the incidence
of VF. Seven fatty acids were significantly correlated
(p<0.1 ) with the incidence of VF (Table 3.4).
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TABLE 3.4 Correlations between the statistically






R value P value
PI 20:3(n-9) -0.858 < 0.01
PC 18:1(n-9) -0.729 < 0.05
PE 18:2(n-6) -0.674 < 0.1
PE 20:3(n-6) -0.723 < 0.05
PE 20:4(n-6 ) -0.600 < 0.1
CL 18:2(n-6 ) -0.697 < 0.1
CL 20:4(n-6) 0.622 < 0.1
3.3.4 Fatty acid composition of adipose tissue.
All measured fatty acids in adipose tissue
differed between the 6 rat strains except 20:1 (n-9)
and 22:6 (n-3) (Table 3.5).
The P/S ratio was lower in the SHR strain in
comparison to other inbred strains (p<0.05 ; Table
3.3). This is due to a reduction in PUFA, primarily
linoleic acid.
Low dietary linoleic acid, which is associated
with low levels in adipose tissue may lead to serious
ventricular arrhythmias in rats [138], However, no
correlation was seen with linoleic acid in this
experiment, although both 16:0 and 20:3(n-6) correlated
with VF (r= 0.738 and -0.699 respectively).
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TABLE 3.5 Adipose tissue fatty acids in different rat
strains which were statistically significant (p<0.05).
(Units = percentage of total fatty acids)
FATTY ACID INBRED STRAIN
WKY
Saturated





































































































sats 30.12 29.85 26.99 30.96 31 .48 29.77
puf a 15.10 15.90 1 5.60 15.47 1 3 . 42 1 5.88















Heart rate over the first 9 minutes of occlusion
depended on the strain studied (F = 24.50 ; p<0.001)
and, to a lesser degree on the time after coronary
artery ligation (F = 4.09 ; p<0.05). A trend was obser¬
ved for increasing heart rate with increased incidence
of VF. A correlation was found between mean overall
heart rate and the incidence of VF (r=0.899; p <0.01;
Figure 3.6)
FIGURE 3.6. - Correlation of the overall heart rates of















3.3.6 Measurements to assess ischaemia.
Statistically significant differences were seen
in the initial, 15 min occlusion and reperfusion
1 01
coronary flows between the different strains (Table
3.6). The differences in flow rate (expressed as
ml/min/g heart weight) were the result of the increased
heartrbody weight ratios of the MRC hypertensive strain
and the SHR strain.
TABLE 3.6 - Statistically significant differences in
in coronary flow.
Coronary flow
Strain Initial 1 5 min
(ml/min/g)
Reperfusion
WKY 9.03b 5.61 d 7.25bd
(4.91) (5.08) (4.52)
Hypertensive 6.21 c 3.49ac 4.08abe9
(2.15) (1 .14) (1 .21 )
Hunter 7.93a 5.68ab 6.23ac
(2.45) (2.40) (2.15)
F344 9.56cd 5 . 35d 6.25ef
(3.11 ) (3.27) (2.60)
SHR 5.36abde 2.54bce 3.36cdfgh
(1.19) (0.98) (1 .72)
Lew 7. 48e 4. 52e 6.28h
(2.39) (1 .89) (2.51 )
Identical symbols indicate significance between the
groups in the vertical plane after unpaired t-test ;
P< 0 . 05.
3.3.7 Body and heart weights.
Final body and heart weights showed significant
differences between strains (Table 3.7).
Heart weight is known to be correlated with body
1 02
weight [139] and this was confirmed. However, the SHR
and MRC hypertensive strains both have enlarged hearts,
due to their expected hypertrophy, and are the
exceptions.
TABLE 3.7 Final body weights, heart weight and
heart:body weight ratios.
STRAIN BODY WEIGHT HEART WEIGHT HEART:BODY
(Grams) (Grams) (Grams)
WKY 308a 1.007a 3>27a,b,c,d
(41.31) (0.121) (0.16)
HYPER- 323 1.305b 4.02e'f'g
TENSIVE (42.45) (0.325) (0.79)
HUNTER 270b,c 0.808b,c 3.01e'h'1'^
(65.56) (0.197) (0.30)
F344 339d'e 0.910d'e 2.69c'j,k
(24.16) (0.055) (0.17)
SHR 306d'f 1.158a,c,e 3.79b'1'k'1,m
(15.56) (0.069) (0.29)
LEW 3?1a,c,e,f 1>048d 2.82g,d'm
(15.67) (0.087) (0.16)
OBESE 431b 1.018 2.36h'e'a'X
(34.07) (0.130) (0.17)
ANOVA^ F=14.35 F=11.05 F=26.23
Identical symbols indicate statistical significance
between the 2 groups in the vertical plane after
unpaired t-test ; p<0.05.
# Overall statistical analysis of variance
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3.4 - Discussion.
Clinical studies have identified genetic predis¬
position to sudden cardiac death in the long QT
syndrome and hypertrophic cardiomyopathy (HOCUM) [140]
[141]. To date no experiments have been designed to
study the genetic influence on sudden death during
acute myocardial ischaemia. This is the first report to
suggest a genetic influence on the incidence of VF
during acute myocardial ischaemia in different strains
of animals within one species. The results in Figure
3.3 show that there was a variation in the incidence of
VF in the inbred rats screened. The high incidence of
VF in the Lew strain allowed a reduction of the min¬
imum group size from 80 to 32 in our particular experi¬
mental design and consequently more dietary interven¬
tions could be studied. The choice of strain and not
simply the species is therefore an important consider¬
ation when designing a study.
No significant differences were seen in the
incidence of VT or reperfusion VF. From a statistical
point of view it could be argued that the group size
was too small to show a significant decrease in VT.
Therefore, an increase in numbers could show a similar
statistically significant variation for VT, as observed
with VF. The incidence of reperfusion VF in this model
was unaffected in different strains,possibly indicating
that the mechanism for reperfusion VF differs from
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ischaemic VF as has been reported by other researchers
[142]. The very high mean incidence of reperfusion VF
could be a result of the reduction in K+ (from 5.6mM
to 3.1mM) and/or a result of the semi-synthetic high
fat diet. A trend was also observed towards an
increased duration and earlier onset with an increase
in VF incidence. The very high standard deviations for
the onset and duration of VF suggests greater numbers
would be required for full statistical analysis of
these particular parameters.
Experimental evidence suggests that membrane phos¬
pholipids could be involved via three different
mechanisms, either individually or in combination.
First, a relationship was observed between the
relative amount of PI and the incidence of VF
(r=-0.920). PI is the precursor of PI?2 which generates
IP3, a second messenger, which is involved in the
2
control of Ca homeostasis in the cell [143]. The
results suggest an increased hydrolysis of PI and its
phosphorylated products by phospholipase C during
ischaemia. This is supported by a recent paper which
reported accumulations of radiolabelled inositol mono¬
phosphate, inositol bisphosphate and inositol tri¬
phosphate in reperfusion fluid after 30 minutes of
global ischaemia [144]. This situation could lead to an
2 +
influx of Ca into the cell and thereby induce VF.
Ca^+ influx is generally recognised as arrhythmogenic
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[145] lending further support to this particular hypot¬
hesis. Further experiments to determine the effect of
coronary ligation on PI turnover, PI metabolites and
Ca^+ would establish a greater understanding of the
possible involvement of this mechanism.
The experimental results here also indicate phospho¬
lipid compositional changes which may alter prostanoid
production and hence the incidence of ischaemic VF.
Prostanoids have been reported by several workers to be
involved in an antiarrhythmic mechanism [71] [146]
[147]. PGI2 and the synthetic analogue iloprost have
been identified as antiarrhythmic in the isolated per¬
fused heart [146] [148]. The results in this chapter
suggest a possible involvement of 20:4(n-6) in PE
(r = -0.6) and 20:4(n-6) in CL (r = 0.622) in the
genesis of VF. The arachidonic acid in CL only repre¬
sents 3% of the total fatty acids in the heart whereas
in PE it accounts for 28%. CL is found predominantly in
the mitochondrial membrane [149] and its relation to
prostanoid synthesis is obscure. In contrast, the
changes in arachidonic acid in the PE fraction could be
of greater importance for prostanoid synthesis in the
sarcolemmal membrane. Increased incorporation of ara¬
chidonic acid into PE might increase the precursor
available for prostanoid synthesis, which in turn
increases prostanoid production. PG^ is the major
prostanoid secreted by the isolated perfused heart
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[150] and Coker et al have shown PGl^ to be anti¬
arrhythmic [146]. Therefore, changes in arachidonic
acid levels in PE may be the mechanism by which the
genetic variation in VF is controlled. Measurement of
prostanoids and monitoring the effects of prostanoid
inhibitors would have provided more information and
this will be examined in Chapter 6.
Changes in the composition of other PUFA's in
myocardial phospholipids also correlated with the
incidence of VF and suggested the possible involvement
of yet another factor (Table 3.4). As early as 1930 the
n-6 fatty acids were discovered to be essential for
several biological functions, including maintenance of
normal membrane function [52]. As yet, the specific
role of the n-6 PUFA in membranes has still to be
established. The n-6 PUFA's show major compositional
changes in the present study as well as 20:3(n-9) in
PI. The membranes of some of the rat strains could
have been partially EFA deficient, causing alterations
in membrane function and leading to VF, since 20:3(n-
9) is considered an indicator for EFA deficiency [151],
However, the correlation with VF was negative,
elevated 20:3(n-9) accompanied a decreased incidence of
VF. Futhermore no external indicators of EFA deficiency
were observed (ie scaly skin, loss of hair etc) and the
animals were all fed the same diet which contained 3%
energy from linoleic acid (sufficent to satisfy EFA
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requirement). Increased levels of all the PUFA1s
identified correlated with decreased VF. As the fatty
acids in question were all highly unsaturated, they
could have exerted their effect directly by an increase
in membrane fluidity [98]. No evidence exists to illus¬
trate that an increase in fluidity alters the activity
of transmembrane proteins in the myocardium, but it is
an area of considerable study. The fatty acids in this
experiment could have increased the number of funct¬
ional ion channels or the activity of existing ion
channels. To confirm the role of this particular hypo¬
thesis, specialised studies on the effect of PUFA'S on
transmembrane function, either in-vivo or in-vitro,
would have to be carried out.
Previous studies have identified a possible
involvement of heart rate in ischaemic VF. Increased
heart rate results in increased oxygen consumption and
hence increased ischaemic damage and predisposition to
VF [152], Changes in heart rate may also predict VF by
reflecting increased catecholamine release, which is
assumed to lead to ischaemic arrhythmias [153]. It was,
therefore, of interest that increased heart rate corre¬
lated with an increased incidence of VF. In the experi¬
mental model used here sympathetic nerves have been
severed but catecholamine release can still be observed
as a result of direct noradrenaline release from the
nerve endings [154]. Direct measurements of catechol-
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amine release and high energy nucleotides could
validate this statement further. Heart rate in diff¬
erent mammals has been reported to correlate to the
relative amount of 22:6(n-3) in myocardial total phos¬
pholipid and PE [155]. The data from this experiment
showed a correlation (p<0.1 ) between 22:6(n-3) in PE
and heart rate, but no relationship with its relative
amount in total phospholipid. No correlation of 22:6(n-
3) in PE with the incidence of VF was found suggesting
this is probably not the mechanism responsible for the
difference in the incidence of VF between the various
rat strains.
Adipose tissue fatty acid composition has been
shown to be an indicator of dietary fat intake [156].
In this experiment all the animals were fed the same
diet, but statistically significant differences were
still observed (Table 3.5). A selective mechanism for
deposition of dietary fat adipose tissue has not been
demonstrated. It is simply a storage depot for excess
fat. Thus, these findings suggested either a selective
process of fat absorption, processing in the
liver, or an incomplete equilibration of dietary fatty
acids with body adipose tissue. Changes in the absor¬
ption of specific triglycerides could lead to some
fatty acids being incorporated into phospholipids in
the liver and others being oxidised. A variation in the
metabolic rate of the animal would alter the turnover
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in adipose tissue, and the fatty acid pattern observed
could be predominantly that of the previous dietary
intake. Differing activities of delta-6 and delta-5
desaturase between strains would also effect the
utlimate fate of linoleic acid. Therefore the relative
amounts of fatty acids in adipose tissue, originally
from endogenous and exogenous fatty acid sources, could
be changed. Another possible effector could be the
maternal diet, which was uncontrolled in these exper¬
iments. This has been identified as an important
indicator in arrhythmia experiments in a collabortive
experiment with Organon [157]. In this experiment
enquiries to the animal suppliers involved in this
study revealed that all animals had been bred on the
same 'Labsure' diet suggesting this factor was not of
great importance. However, analysis of Labsure diet
over a 6 month period revealed that significant varia¬
tions in the EFA's 18:2 (n-6) and 20:5 (n-3) occur
(Table 3.8).
Genetic influences on a number of biochemical
processes appear to be the major factor responsible for
the composition of fatty acids in adipose tissue and
perhaps the incidence of VF. However, further experi¬
ments would have to be carried out to elucidate the
roles of the various effectors.
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TABLE 3.8. - Variation in EFA composition of Labsure
diet over 6 month period.
MEAN S.D C.V
(%) (%) (%>
18:2(n-6) 49.51 4.26 8.6
20:5(n-3) 1 .61 60 37.8
C.V. = coefficent of variation.
Interesting observations, secondary to the aim of
this experiment, were made in the case of hypertension
and its relationship to arrhythmias. Hypertrophy of the
heart has been linked with increased cardiac damage
during ischaemia [158] and an increased incidence of VF
was expected. Indeed the incidence of VF in the SHR
strain was higher than the WKY control strain. In
contrast, the hypertensive strain from the MRC unit
Edinburgh showed a significantly lower incidence of VF
in comparison to the SHR rats, but no difference in VF
when compared to the normotensive WKY. Thus, even in
this case alternative, presumably genetic factors
operate. Furthermore, the developmental stage of hyper¬
tension has been linked to vulnerability in the
ischaemic situation [159]. But, heart to body weight
ratios showed no difference between SHR and hyper¬
tensive rats suggesting this was not involved. These
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results therefore identify the hypertensive and SHR as
models of interest in the study of hypertrophy and its
relationship to VF.
In conclusion, this experiment has identified a
strain with a high incidence of VF fed a standardised
'control' diet. A number of mechanisms for the diff¬
erences in the generation of VF have been proposed from
the results of myocardial phospholipids and adipose
tissue fatty acid analysis, as well as from other
factors known to relate to VF. The major factor acting
on the different strains, responsible for the variation
in the incidence of VF appears to be the genetic
control of dietary fat incorporation into myocardial
phospholipids, which in turn may influence various
phospholipid functions. This study was not designed to
test these factors, but further experiments would be
merited to clarify their importance.
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CHAPTER 4
N-6 FATTY ACIDS AND VENTRICULAR FIBRILLATION.
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4.1 Introduction.
Fats form an important constituent of mans diet
and provide a considerable source of energy (-40% of
total energy in Western industrialised societies [62]).
An awareness has developed that excess dietary fat is a
major risk factor for coronary heart disease in man.
Simultaneously there is general agreement that sat¬
urated animal fat is detrimental to health and should
be reduced. Accordingly the World Health Organisation
has recommended an ideal dietary fat intake of 30%
energy and a minimum P/S ratio of 1.0 [42].
Diets enriched in PUFA predominantly 18:2(n-6)
having a high P/S ratio, may reduce the incidence of
ischaemic ventricular fibrillation in animals [39] [40]
[41] [72]. These studies have all used standard labora¬
tory chow supplemented with fat, but the study of such
diets poses several problems. Firstly, the high calor¬
ific content of the fat supplement results in a red¬
uced intake of the basic chow which contains all essen¬
tial vitamins and minerals. Secondly, the diets used
were very extreme fat diets, which could not be con¬
sumed by man, e.g. a P/S ratio of 6.46 [39]. Consequen¬
tly an effect on ischaemic VF cannot simply be attri¬
buted to the higher intake of polyunsaturated fatty
acids. The content of vitamin E was not controlled and
low levels of this vitamin have been linked v/ith sudden
death and VF [120]. The first aim of this chapter was
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to use isocalorific diets to confirm or otherwise the
possibility that the antiarrhythmic effect observed in
the previous studies was indeed due to the increased
content of polyunsaturated fatty acids. Furthermore,
the diets to be tested would not be so extreme as to
preclude extrapolation of the results to man. The diets
chosen was the average diet consumed by Scottish men
(40% energy fat P/S=0.3, control diet) and the achieva¬
ble ideal (P/S ratio of 2.0 40% energy fat).
A reduction in total fat consumption, as reco¬
mmended, would invariably result in a reduction of
polyunsaturated fatty acids. Therefore the secondary
aim of this chapter, was to examine whether the anti¬
arrhythmic effect of a linoleic acid rich diet could be
maintained in 'prudent' low fat diets. The relative
amount of energy from fat of 40%, 30% and 20% total
dietary energy was studied. These reductions may not
appear large in numerical terms, but they correspond to
a 25 and 50% reduction in the average Scottish man's
daily dietary fat intake.
4.2 - Methods.
6 diets were calculated to give the energy and P/S
ratios shown in Table 4.1 using the method described in
section 2.2. The reduction in dietary fat was compen¬
sated for by a corresponding increase in carbohydrate
intake. The specific ingredients for each diet are
shown in Appendix 4.
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TABLE 4.1. The calculated fatty acid composition of the
diets with percentage energy from fat of 20%, 30% and
40% and a P/S ratio of either 0.3 or 2.0.
Total P/S I. D. MONO SAT POLY
Energy Fat (%en) (%en) (%en)
(%en)
40 2.0 1 1 4 8.67 1 7.33
30 2.0 2 10.5 6.50 1 3.00
20 2.0 3 7 4.33 8.67
40 0.3 4 1 4 20.00 6.00
30 0.3 5 10.5 1 5.00 4.50
20 0.3 6 7 10.00 3.00
240 eight week old male Lew rats were randomly
assigned to one of the six diets and placed on their
particular diet at staggered time intervals. Animals
fed the 'Scottish' diet (ie 40% energy fat and P/S
ratio of 0.3) were studied simultaneously as a control.
After 8 weeks feeding, the effect of coronary ligation
on ventricular arrhythmias was examined using the
Langendorff in-vitro perfusion system and the protocol
described in Section 2.4. The perfusions were carried
out in collaboration with S Rebergen (student project).
Adipose and heart tissue was taken and analysed for
triglyceride and phospholipid fatty acid compositions
as stated in Section 2.3.3-2.3.5. Both total phopho-
lipid and each phospholipid fraction were analysed to
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investigate if total phopholipid was representative of
the changes in each fraction.
All perfusion experiments were treated with the
'exclusion criteria' (Section 2.4.2) and the remaining




The incidence of ischaemic VF at each energy level
was reduced by feeding polyunsaturated fatty acid rich
diets (Figure 4.1). This was not so for ischaemic VT
(Figure 4.2). Significant differences between onset of
VF and VT and duration of VT (Table 4.2) were seen, but
none of these values correlated with the incidence of
ventricular fibrillation.
All perfusions met the criteria stated in section
2.4.2, but the severity varied (Table 4.3). The
operator differences do not affect the final results,
as the more severe ischaemia were predominantly in the
20% fat groups which had a lower incidence of VF.
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FIGURE 4.1 - Incidence of VF during acute myocardial
ischaemia in the isolated perfused rat hearts after
feeding of diets with different P/S ratio and total fat
intake.
Identical symbols indicate statistical significance
between the two groups after the Chi-square test, a,
p<0.05 ; b,c, p <0.001
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FIGURE 4.2 - Incidence of VT during acute myocardial
ischaemia in the isolated perfused rat hearts after
feeding diets with different P/S ratio and total fat
intake.
VT% 120-1
20 30 40 en%FAT
(N.S. after Chi-square test)
TABLE 4.2 - Onset of VF and VT and duration of VT in










40% P/S 2.0 10.95 abcde2.14 a10.07 c0.27
30% P/S 2.0 a1 0 .1 8 C7.25 b9 .11 d0 .52
20% P/S 2.0 b12.47 e5.03 9.74 bf0.36
40% P/S 0.3 11.10 a5.70 abc9.23 ab0.55
30% P/S 0.3 ab11.83 b5.30 C8.80 ae0.43
20% P/S 0.3 1 3.67 d4.62 9.71 cdef0.84
Identical symbols indicate significance between the two
groups in the vertical plane after Mann-Whitney test ;
a-f p<0.05
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TABLE 4.3 - The reduction in coronary flow after
coronary artery ligation in relation to the operator.
Diet % Reduction in CF Operator
(ml/min/g)
40% P/S 2.0 30.38 (9.0) SR
30% P/S 2.0 27.10 (11.1) SR
20% P/S 2.0 38.29 (11.6) CS
40% P/S 0.3 25.88 (10.5) SR + CS
30% P/S 0.3 28.48 (10.9) SR
20% P/S 0.3 38.71 (12.2) CS
Figures in bold type indicate significant differences
from all the other diets after unpaired t-test ;p<0.05.
(SR = vS. Rebergen ; CS = C. Sargent).
4.3.2 Relationship between dietary fat and the
incidence of VF.
The dietary saturated (r = 0.825 ; p<0.05) and
polyunsaturated fat (r = -0.900 ; p<0.01) contents were
related to the incidence of VF. In contrast dietary
monounsaturated fatty acids showed no correlation
(r = 0.600 ; N.S.).
4.3.3 Fatty acid composition of myocardial
phospholipids.
Polyunsaturated fatty acid composition of the
total phopholipid of hearts from animals fed a low P/S
ratio differed from those fed a high P/S ratio while
1 20
saturated and monounsaturated fatty acids remained
unaltered. Numerous fatty acid differences were also
found in each of the 5 phospholipid fractions (Table
4.4). The changes in PUFA were predominantly in the n-6
family (Table 4.4). However no differences occurred in
the major n-6 fatty acid, arachidonic acid at 30% or
40% energy from fat.
To identify the possible physiological signifi¬
cance of these changes in fatty acid composition with
respect to the reduction of VF seen at all dietary fat
contents, further analyses were required. It was pro¬
posed that any changes in fatty acid composition
involved in the antiarrhythmic mechanism would be
statistically significantly different at each fat con¬
tent. Using this criterion, 8 fatty acids which could
be involved were identified (fatty acids in bold type
in Table 4.4). These PUFA's constituted very small
percentages of each fraction (Table 4.5). To assess the
involvement of these 8 fatty acids in the genesis of
VF, correlations were investigated. Only four of the
original fatty acids reached significance (Table 4.6)
and they were all in the phospholipid fractions.
An unexpected increase in the number of fatty acid
differences between the high and low P/S ratio in the
low fat diet (2 0% ; n = 32) were seen v/hen compared
with the 30% and 40% energy fatty acid results (30% ;
n = 15 and 40% ; n = 9 ; Table 4.7).
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TABLE 4.4 - PUFA which are






























Bold figures indicate fatty acids in each fraction
which are significantly different at each energy level.
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TABLE 4.5 - Statistical significant PUFA's identified
at each energy level and the percentage they occupy in
the particular fraction.
DIET
Fraction 40% 30% 20% 40% 30% 20%
P/S 2.0 P/S 0.3
PI 20:3 (.06%) (.06%) (.09%) (.15%) (.19%) (.21%)
(n-9)
PC 18:2 (8.0%) (8.9%) (8.2%) (6.5%) (6.0%) (7.4%)
(n-6)
20:2 (.08%) (.09%) (.10%) (.02%) (.03%) (.07%)
(n-6)
PE 20:2 (.07%) (.11%) (.07%) (.01%) ( * ) ( * )
(n-6)
22:4 (2.3%) (2.4%) (2.7%) (1.7%) (1.6%) (1.7%)
(n-6)
TPL 20:2 (.11%) (.11%) (.07%) (.04%) (.02%) (.02%)
(n-6)
20:3 (**)(**)(**) (.01%) (.01%) (.02%)
(n-9)
22:4 (1.3%) (1.2%) (1.3%) (1.0%) (1.0%) (0.8%)
(n-6)
* indicate <.01% ; ** indicate <0.004%
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TABLE 4.6 - Fatty acids which correlate with the
incidence of VF.




PC 18:2 (n-6) -0.830 0.05
PC 20:2 (n-6) -0.845 0.01
PE 20:2 (n-6) -0.901 0.01
PE 22:4 (n-6) -0.840 0.01
TABLE 4.7 - Number of fatty acids with statistically



























4.3.4 Levels of myocardial phospholipids.
Significant differences were found in the levels
of the myocardial phospholipid fractions (Table 4.8).
TABLE 4.8 - Myocardial phospholipid levels after
feeding 20%, 30%, and 40% energy fat diets with a P/S
ratio of 0.3 or 2.0.
Diet PI PS PC PE CL TPL













4940 3760 1549 10893
4929 3681 1411 10607
5886 3805 2132 10642





Figures in bold print indicate statistical significance
in the vertical plane from the values not in bold print
(p<0.05) after unpaired t-test;
4.3.5 Fatty acids composition of myocardial
triglycerides.
The amounts of myocardial triglyceride were
identical in all the animals (mean = 1435 ug/g heart
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tissue). However, significant differences were found in
myocardial triglyceride fatty acids composition between
the high and low P/S ratios (Table 4.9).
TABLE 4.9 Statistically significant fatty acids in
myocardial triglycerides, P/S ratio 0.3 and 2.0 at each
energy level.
40% energy fat 18:0
30% energy fat 18:0
20% energy fat 18:0, 20:0, 18:2(h-6), 20:2(n-6), 20:3£n-9)
4.3.6 Fatty acid composition of adipose tissue.
Adipose tissue fatty acid composition differed
between P/S 0.3 and 2.0 diets, irrespective of the
percentage of fat (Table 4.10). Further statistical
correlation analysis of the incidence of ventricular
fibrillation identified several fatty acids could be
indicators of an animal's propensity for arrhythmias
(Table 4.11).
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TABLE 4.10 Statistically significant fatty acids in
adipose tissue between P/S ratio 0.3 and 2.0 at each
energy level
DIET
40% 30% 20% 40% 30% 20%

























































































Fatty acids which are staistically significantly
different (p<0.05) between P/S ratio 2.0 and 0.3 at
each energy level (expressed as % of total fatty acids)
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TABLE 4.11 - Fatty acids in adipose tissue which









20:1 # -0.952 0.001
18:2(n-6) -0.918 0.01
#20:1 is a complex peak with 18:3n-3.
4.3.7 Heart rate.
No significant differences were found in heart
rate (0, 5 and 10 min occlusion).
4.3.8 Measurements to assess ischaemia.
The dietary fatty acid composition did not modify
lactate production until 15 minutes after occlusion
(Table 4.2). Statistically significant differences in
LDH, reperfusion lactate and an increase in lactate
production were also found (Table 4.12). LDH and the
increase in lactate production had significant inverse
correlations with the incidence of VF (r = -0.775;
p<0.05 and r = -0.918; p<0.01 respec-tively), contrary
to what was expected.
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TABLE 4.12. - Statistically significant parameters
measured to assess the degree of ischaemia.
Lactate LDH
increase 15 min reperfusion reperfusion
40% P/S 2.0 abc .610 .461
30% P/S 2.0 defg .649 .745
20% P/S 2.0 ad .430 .934
40% P/S 0.3 be .395 .953
30% P/S 0.3 cf .256 1 .333
20% P/S 0.3 g .502 1 .057
abc 2.60
a 1.90 bfij .440








Identical symbols indicate significant differences
between the two groups in the vertical plane; p<0.05.
The figure in bold print indicates significant
differences between all values in the column; p<0.05.
(LDH Units/min/g ; lactate uM/min/g)
4.4 - Discussion.
This experiment confirmed an antiarrhythmic effect
of isocalorific, semi-synthetic diets rich in linoleic
acid at fat levels of 40 and 30% energy. However,
although still present at 20% energy, the effect was
attenuated. The incidence of VT was unaffected by alt¬
erations in linoleic acid levels. Variations in the
onset of VF and VT as well as the duration of VT showed
no correlations with VF, suggesting they were unrelated
to the antiarrhythmic effect. Reperfusion VF was unal-
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tered throughout with the high incidence as seen in
Chapter 3 maintained no matter what diet. The inability
to alter this parameter meant that it could be omited
from future dietary experiments. The ischaemic area of
myocardium was operator dependant, as indicated by the
difference in percentage reduction in coronary flow.
The greatest reductions in coronary flow were in the
experiments carried out by myself, the 20% fat diets.
However, these diets had the lowest incidence of VF in
the 'control' diet group, thereby illustrating that a
more severe occlusion did not increase the incidence of
VF, as has been previously documented [160]. The other
dietary groups did have smaller occluded zones, but the
experiments all reached the criteria stated in Section
2.4.2. Therefore, in conclusion, the results for the
incidence of arrhythmias were unaffected by the oper¬
ator differences in the degree of occlusion.
Correlations with the incidence of VF and the
dietary fatty acid classes identifed an inverse rela¬
tionship with saturated and polyunsaturated fatty
acids. In contrast, no correlations were found with
dietary monounsaturated fatty acids, suggesting that
they were not involved in the antiarrhythmic effect.
Diets rich in linoleic acid altered myocardial
phospholipid fatty acid composition. Analysis of total
phopholipid plus the specific phospholipid fractions
identified, not suprisingly, the predominant fatty acid
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changes to be increases in n-6 fatty acids. The in¬
creases were either in linoleic acid directly or its
elongation/desaturation products. Comparison of the
fatty acid changes in total phospholipid with previous
publications [39] [161] differed, in the absence of an
increase in 20:4(n-6) and a decrease in n-3 fatty
acids. The decreases in n-3 fatty acids previously
documented with linoleic acid rich diets could be due
to the units in which the results were expressed.
Previous publications used percentage composition,
whereas, the results in this chapter are expressed as
ug fatty acid/g heart weight. The fatty acid increases
found in this chapter constitute very small components
of the particular phospholipid fraction. Therefore, a
corresponding decrease in a large component could
possibly be undetectable. The n-6/n-3 ratio shows a
non-significant increase in the hearts fed linoleic
acid rich diets, but the P/S ratio was maintained in
all phospholipid fractions.
The consistent fatty acid changes in total phopho-
lipid were 20:2(n-6) and 22:4(n-6). The greatest number
of compositional changes were in PC and PE phospholipid
fractions, in agreement with previous investigators
[32] [83], thereby indicating their susceptibility to
dietary modification. The alterations seen in 22:4(n-6)
in total phopholipid correspond specifically to changes
in the PE fraction. The changes of 20:3(n-9) in total
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phopholipid relate to the PI fraction and 20:2(n-6)
alterations correspond to the PC and PE fractions. Many-
fatty acids in the fractionated phospholipids reached
statistical significance that were not significant in
the total phospholipid thereby emphasising the import¬
ance of analysing the individual phospholipid frac¬
tions .
If a phospholipid fatty acid compositional change
was involved in the genesis of VF it would be signif¬
icantly different at each energy level and would corr¬
elate with the incidence of VF. 20:2 (n-6) in both PC
and PE were significantly correlated with the incidence
of VF. 20:2 (n-6) is considered an 'inactive end
product' and constitutes less than 1% of PC and PE.
Therefore its biological importance is probably
minimal. 22:4 (n-6) in PE and 18:2(n-6) in PC also
correlated with VF. In contrast with 20:2(n-6), they
constitute up to 2.5% and 9% respectively and could
conceivably affect biological action in the myocardial
membrane. Although 20:3(n-9)was significant at each
energy level it did not correlate with VF and could
therefore be discounted from any involvement in the
generation of VF. The increased levels in the low
linoleic acid diets are indicative of EFA deficency,
however all diets had sufficent energy from linoleic
acid to prevent EFA deficiency (3% ; [162]). Inter¬
estingly, no fatty acids identified in total phopho-
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lipid correlated with the incidence of VF. This could
be because the changes found in the fractions were very-
small proportions of the total phospholipd which could
be masked by the other bulk unchanged fatty acids. This
further emphasises the importance of analysing the
fractionated phospholipids, not just the total phopho-
lipid. Further studies to confirm if the changes in
22:4(n-6) (PE) and 18:2(n-6) (PC) were specific to the
sarcolemmal or mitochondrial membrane would further the
understanding of the possible involvement of these
fatty acids in the generation of VF, as would studies
which investigated the association of these fatty acids
with specific phospholipid molecular species.
The distribution of fatty acids in myocardial
phospholipids between the 2 diets was unchanged at 40
and 30% energy fat. However, at 20% energy both the P/S
0.3 and P/S 2.0 diets showed a significant increase in
the amount of fatty acids incorporated into both PC and
CL. The total amount of phopholipids were unchanged and
the shift in phospholipid composition was assumed to be
unimportant in the development of VF, as it occurred
in both the low and high linoleic acid diet. The
changes could be responsible for the increased number
of differernces in fatty acid composition between the
P/S 0.3 and 2.0 diets in the 20% energy fat diets. The
significant increases in arachidonic acid in animals
fed 20% fat linoleic acid rich diet could explain the
1 33
apparent disagreement between our results and previous
publications. Perhaps, with 40% energy fat, linoleic
acid oxidation is increased in the rat. The increased
arachidonic acid levels found in myocardial total phos¬
pholipid by Lepran et al [39] in rats fed linoleic acid
rich diets could be a result of the amount of fat fed
and not be involved in any antiarrhythmic effect.
Several other parameters were found to correlate
with the incidence of VF. Decreased linoleic acid and
increased 16:0 and 18:0 in adipose tissue correlated
with VF and their dietary precursors. Therefore, varia¬
tions in these adipose tissue fatty acids could be
indicators of a rat's propensity for VF. Increased
lactate and LDH production were probably the result of
variations in the size of the ischaemic area and are
indicative of the tissue's inefficiency in aerobic
energy production. Triglyceride stores in the heart are
unchanged and thereby discount an influence of dietary
fat in energy metabolism.
In conclusion, this experiment confirmed linoleic
acid rich diets were antiarrhythmic at 40%, 30% and 20%
energy fat. The effect was attenuated at 20% energy
suggesting the type rather than the amount was the
dominant factor in an antiarrhythmic effect. No var¬
iations in the levels of arachidonic acid in myocardial
total phospholipid tend to discount any prostanoid
involvement. However, the arachidonic acid levels
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required for prostanoid production are small and may
not be measureable. Experiments with a specific prost¬
anoid inhibitor would have to be carried out to confirm
they are not involved (Chapter 6). A further confounder
has been identified, the concomitant decrease in
dietary saturated fatty acids with linoleic acid rich
diets. The importance of this decrease is unknown and
also merits further study.
The alterations in levels of 22:4(n-6) in PE,
18:2(n-6) in PC and 20:2(n-6) in PC and PE in the
myocardial phospholipid membrane have been shown to
correlate with the antiarrhythmic effect observed with
linoleic rich diets. These may alter membrane protein
functions or energy control and hence be directly invo¬
lved in the antiarrhythmic effect. Further experiments
would have to be carried out to test the biological
consequences of such relationships and to remove the
effect of any confounders.
1 35
CHAPTER 5
ASSESSMENT OF THE RELATIVE IMPORTANCE OF DIETARY




The previous chapter confirmed that isocalorific
diets rich in linoleic acid reduce the incidence of
ischaemic VF. Diets rich in linoleic acid are corres¬
pondingly low in saturated fatty acids. Therefore, the
widely held view that an antiarrhythmic effect is due
solely to increased linoleic acid in the diet is not
warranted [39], [40], [72].
The Seven Countries study [162] described a rel¬
ationship between the consumption of saturated fat by
man and the standard mortality rate of CHD. Furthermore
a clinical study of patients with acute myocardial
infarction identified adipose tissue saturated fatty
acids as an indicator of the risk of development of
serious ventricular arrhythmias [57]. The incidence of
VF in Langendorff perfused rat hearts is directly cor¬
related with dietary saturated fat (r=0.825) and inver-
sley correlated with dietary polyunsaturated fat
(r=-0.900) (Chapter 4 ; [163]). No correlation with
dietary monounsaturated fatty acids were found sugges¬
ting they were not involved in an antiarrhythmic effect.
Such data emphasises the need to address the
relative role of saturated fats in the antiarrhythmic
effect of linoleic acid rich diets. However, no dietary
experiments to date have been carried out to test
whether beneficial effects are due to (a)decreased
saturated fat, (b)increased polyunsaturated fat, or
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(c) a combination of (a) and (b). Therefore, the aim of
this experiment was to identify which class of fatty
acid exerted the greater effect, linoleic acid or
saturated fatty acids. To study this problem, a multi¬
factorial experiment was designed to test the effect of
changing dietary polyunsaturated and saturated fatty
acids in parallel, whilst maintaining a constant P/S
ratio and energy from fat by manipulating the content
of monounsaturated fatty acids. A low P/S ratio diet
(-0.3) was also included to act as a control.
5.2 - Methods.
Four diets were formulated to test the involvement
of saturated fatty acids in the antiarrhythmic effect
of linoleic acid rich diets, as described in Section
2.2 (Table 5.1). To achieve maximum increases and dec¬
reases of polyunsaturated and saturated dietary fatty
acids, maintain a constant P/S ratio and avoiding EFA
deficiency the amount of fat in the diet had to be
increased to 50 % energy.
160 male, 8 week old Lew rats were allocated
randomly to one of the 4 dietary groups. After 8 weeks,
the animals were studied as described in Chapter 4. The
incidence of VF in the control group was only 21%,
making any statistical conclusions on arrhythmias impo¬
ssible with the numbers available. Therefore the expe¬
riment was repeated 6 months later. VF in the control
group in the second experiment (perfused by L. vanVeen
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; student project) was also low, 30 % (N.S. from the
first study) which allowed the results for the two
experiments to be combined.
TABLE 5.1 - Diets calculated to test the role of
dietary saturated fatty acids in the antiarrhythmic
effect produced by linoleic acid rich diets.
POLY SAT MONO P/S ENERGY
(% en) (% en) (% en) ( % )
Diet 1 3.75 6.05 40.20 0.66 50
Diet 2 17.67 28.50 3.83 0.66 50
Diet 3 13.25 21 .50 1 5.25 0.66 50
Diet 4 3.75 16.13 30.12 0.23 50
(the list of ingredients is reproduced in Appendix 4)
5.3 - Results.
5.3.1 Arrhythmias.
The incidence of VF ranged from 12 % to 25 %. The
highest incidence of VF was in the group fed the low
P/S ratio diet, but statistical significance was not
reached (Figure 5.1 ). The results for VT showed a simi¬
lar trend but as was the case for VF, significance was
not reached (Figure 5.2).
The percentage reduction in coronary flow did not
differ between the diets (mean = 39 %) and was similar
to the values in previous experiments, where a high
incidence of VF was found.
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FIGURE 5.1 The incidence of VF after acute coronary
artery occlusion in rat hearts fed diets 1,2,3 or 4.
N.S. after Chi-square test.
FIGURE 5.2 - The incidence of-VT after acute coronary






















(N.S. after Chi-square test)
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5.3.2 Levels of myocardial phospholipids.
The levels of individual phospholipid did not
change (Table 5.2).
TABLE 5.2 Myocardial phospholipid levels after feeding






DIET 2 DIET 3 DIET 4
tPUFA+SAT INTERMEDIATE CONTROL
496 (145) 580 (136) 536 (99)
PS 341 (103) 335 (84) 342 (102) 343 (66)
PC 4624(1351) 4393(1307) 5364 (915) 5371 (724)
PE 3254 (819) 2790 (898) 3170 (733) 3098 (533)
CL 1517 (488) 1384 (571) 1671 (394) 1717(356)
TPL 11808(1172) 12857 (922) 11893 (842) 11758(1133)
(M.S. after ANOVA ; n=8 per group)
5.3.3 Fatty acid composition of myocardial
phospholipids.
Changes in all the fatty acids measured in total
phospholipid, except arachidonic acid were found as
well as numerous changes the 5 phospholipid fractions
(Table 5.3). As there were no differences in the inci¬
dence of VF, the significant changes in the phospho-
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lipid were only correlated with the dietary fatty
acids. In total phospholipid the majority of the fatty
acid changes in the myocardium correlated positively
with the dietary fatty acids, the exceptions being
16:1, 18:0, 20:3(n-6) and 20:3(n-9), the latter because
it isn't found in the diet (Table 5.4). All the fatty
acid differences in PI, PC and PE also correlated with
their dietary precursors, the exception being 20:3(n-9)
and 22:6(n-3). None of the fatty acids identified in PS
correlated with their dietary precursors. 22:6(n-3) was
the only fatty acid in CL which correlated with its
dietary precursor. No correlations of 22:6(n-3) in PI,
PC or PE with its dietary precursors (ie 18:3(n-3) or
20:5(n-3) were found eventhough significant differences
were found between the different diets.
TABLE 5.3 Fatty acids which were significantly
different after feeding diets 1, 2, 3, or 4.
PI 18:1(n-9), 18:2(n-6), 22:5(n-6), 20:3(n-9)
PS 22:5(n-6), 22:6(n-3)
PC 16:0, 1 8:2(n-6), 20:2(n-6), 20:3(n-6),
22:4(n-6), 22:5(n-6), 22:5(n-3), 22:6(n-3),
20 : 3(n-9)




TABLE 5.4 Correlations of statistically significant
fatty acids in myocardial phospholipid with dietary
fatty acids.






fatty acid fatty acid
16:0 16:0 0.91 4 <0.05
18:1(n-9) 18:1(n-S) 0.957 <0.01
1 8: 2tn-6) 18:2*1-6) 0.9 46 <0.01
20:0 20:0 0.840 <0.05
20:1 18:1 0.999 <0.001
20:2n-6) 1 8: 2*1-6) 0.914 <0.05
22:4*1-6) 18:2*1-6) 0.999 <0.001
22:Slxi-6) 1 8: 2*1-6) 0.987 <0.001
22:5*1-3) 18:3*1-3) 0.896 <0.05
22:0x1-3) 1 8: 3*1-3) 0.895 <0.05
1 8:1(n-9) 18:1*1-9) 0.96-1 <0.001
1 8: 2n-6) 1 8:2*1-6) 0.955 <0.001
22:5*i-6) 18:2*1-6) 0.978 <0.001
16:0 16:0 0.867 <0.05
1 8:2*i-6) 18:2*1-6) 0.889 ' <0.05
20: 2*i-6) 18:2*1-6) 0.956 <0.01
20: 3*1-6) 18:2*1-6) 0.858 <0.05
22:4(11-6) 1 8:2(h-6) 0.978 <0.001
22:5*1-6) 18:2*1-6) 0.940 <0.01
22: 5*i-3) 18:3*1-3) 0.931 <0.01
18:1(11-9) 18:1*i-9) 0.935 <0.01
1 8:2*i-6) 18:2h-6) 0.870 <0.05
22:4*1-6) 18:2n-6) 0.994 <0.001
22:5*1-6) 1 8: 2*i-6) 0.934 <0.01
1 8:1(h-9) 18:1(n-9) 0.860 <0.05
22: 6*1-3) 18:3*1-3) -0.847 <0.05
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5.3.4 Fatty acid composition of adipose tissue.
Numerous significant differences were seen in
adipose tissue (Table 5.), the differences observed
relating to the fatty acid composition of the
corresponding diet (Table 5.6).
TABLE 5.5 Statistically significantly different fatty
acids in adipose tissue after feeding animals diets 1 ,
2, 3 or 4% of the total).
Diet 1 Diet 2 Diet 3 Diet 4
FATTY ACID JPUFA+SAT fPUFA+SAT INTERMEDIATE CONTROL
SATS
16:0 9.58a 20.64ab 15.31 14.44b
(0.65) (3.42) (0.39) (2.32)
18:0 2.96a 6.11ab 3.98b 5.60
(0.23) (1.00) (0.20) (0.52)
MONOS
18:1 66.77a 44.91ab 62.59b 62.79
(1.40) (9.60) (0.90) (8.20)
20:1# 0.72a 0.79 0.62ab 0.74b
(0.04) (0.78) (0.03) (0.12)
POLYS
1 8:2(n-6) 1 7.06 23.01ab 14.50a 12.27b
(0.89) (8.90) (0.68) (5.90)
Identical symbols indicate statistically significance
p<0.05 between the 2 groups in the horizontal plane
after unpaired t-test ; n=8 per dietary group.
# complex peak ; 20:1(n-9) plus 18:3(n-3)
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TABLE 5.6 Correlations of the statistically significant
fatty acids in adipose tissue with the dietary fatty
acdis.
Adipose Dietary r value p value
fatty acid fatty acid
16:0 16:0 0.998 <0.001
18:0 18:0 0.998 <0.001
18:1 18:1 0.993 <0.001
18:2(n-6) 18:2(n-6) 0.975 <0.001
20:3(n-6) 18:2(n-6) 0.916 <0.05
5.3.5 Heart rate.
No significant differences were found for heart
rate between the different diets (initial heart rate
= 253 ; mean occlusion heart rate = 215). The values
shown are no different from previous experiments,
suggesting that the low incidence of VF was not linked
to heart rate.
5.3.6 Measurements to assess ischaemia.
Mo significant differences were seen in lactate
or LDH production and the values did not differ from
the results of previous experiments.
5.4 - Discussion.
The very low incidence of VF in the control group
in this experiment meant that, even after combining the
2 studies, the reduction in VF from 26 % to 12 % was
not significant. Only if the incidence of VF had been
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abolished or if the group size was 90 could statistical
significance have been reached. All experiments in both
studies were carried out identically and all the para¬
meters which affect experimental procedure ; animal
growth, ionic concentration of the perfusate, gassing
conditions, initial heart rate, initial lactate, reduc¬
tion in coronary flow and LDH production were no
different from previous studies where the incidence of
VF was high. The fatty acid compositions of adipose
tissue and myocardial phospholipids for the control
animals were no different from those of the control
diets in the previous experiments. This, proves that
the increase in dietary fat from 40 to 50 % energy was
not reponsible for the low incidence of VF.
Other researchers have experienced similar problems
[157] [158] and possible explanations require consid¬
eration. The use of a highly inbred rat strain limits
the influence from genetic variation. Furthermore,
seasonal changes are not relevant in these experiments
since all housing conditions were strictly controlled.
One possibility could be an alteration in the breeding
diets (which could not be controlled) that affects the
developing foetus. One possible candidate could be the
(n-3) polyunsaturated fatty acids in neural tissue
which are known to change following gradual alterations
in dietary (n-3) fatty acids over 3 generations [164].
Nerve cells account for a small percentage of the
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myocardium and therefore any changes in their lipid
composition would be masked by the lipid composition of
the other cell types, which are present in a greater
abundance. Further investigations would have to be
carried out to confirm this particular hypothesis but,
whatever factor is responsible, it overrides any detri¬
mental effect from a poor diet and underlines the need
for a contemporary control group.
The results from the experiment nonetheless indi¬
cate that the dominant dietary influence appears to be
the P/S ratio. Previous unpublished results in our
department have documented the effect of varying the
P/S ratio. Therefore, it appears that the assumption
that increased linoleic acid was solely responsible for
an antiarrhythmic effect [39] [40] [72] is an over
simplification of the situation. Rather, it is the
resulting alteration in the dietary balance of dietary
saturated and polyunsaturated fatty acids which is
responsible for the antiarrhythmic effect. Further
experiments addressing parallel changes of dietary
saturated and polyunsaturated fatty acids and their
relationships with arrhythmias would have to be
studied.
This experiment provided an opportunity to inves¬
tigate the complex control of exogenous fatty acids
incorporation into myocardial phospholipids. These
diets alter PUFA's in the myocardial phospholipids, but
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unlike previously studied diets in Chapter 4, a large
number of changes in saturated fatty acids were
induced. However, the P/S ratio and the amounts of the
particular fatty acids in each phospholipid fraction
were highly conserved, indicating the importance of
these factors in normal membrane function. All the
saturated, monounsaturated and (n-6) polyunsaturated
fatty acids correlated positively with their dietary
precursors, corroborating previous publications [165]
[166]. None of the fatty acid differences identified in
PS correlated with their dietary precursors, implying
that this fraction was very resistant to exogenous
fatty acid alterations. 22:6(n-3) differed in every frac¬
tion except PI, but only in the CL fraction was a
negative correlation found with its dietary precursor,
indicative of the process elongation/desaturation. The
absence of correlation in the other fractions suggests
the possible involvement of an endogenous factor in the
control of its incorporation into phospholipids. 20:5(n-
9) is not found in the diet and does not correlate with
dietary (h-9) fatty acids, but negative correlations were
seen with essential fatty acids (PC r=-0.988 ; p<0.001
with 18:201-6)). All the diets have sufficient linoleic
acid to prevent essential fatty acid deficiency (min¬
imum, 3.75 % energy linoleic acid), and thereby
identify 20:3(n-9)as a sensitive marker for PUFA's in
the membrane, even when a deficiency does not exist.
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The alterations seen in adipose tissue were not as
marked; with 16:0, 18:0 and 18:2(h-6) again being signi¬
ficantly altered by the diets.
In conclusion, these results illustrate the
complex control of exogenous fatty acid incorporation
into myocardial phospholipids and further identify the
importance of maintaining the P/S ratio for normal
myocardial phospholipid membrane function. The perf¬
usion results suggest that the most important factor in
the antiarrhythmic effect appears to be the P/S ratio
and not simply the increased dietary level of linoleic




PROSTANOID INVOLVEMENT IN THE ANTIARRHYTHMIC EFFECT OF
LINOLEIC ACID RICH DIETS.
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6.1 Introduction.
The biologically important prostanoids of the
2-series are synthesised from the n-6 PUFA arachidonic
acid. Prostanoids have been linked with arrhythmias.
Thromboxane B^ has been shown to be arrhythmogenic
[167], wheras, prostacyclin has been demonstrated to
be antiarrhythmic [146]. The major prostanoid secreted
by the isolated perfused rat heart has been reported to
be prostacyclin (68%), with thromboxane being the minor
component (5%) [150]. Diets rich in linoleic acid could
increase prostanoid synthesis by increasing phospho¬
lipid arachidonic acid levels and hence reduce the
incidence of VF. Previous publications have documented
increases in myocardial phospholipid arachidonic acid
levels, after feeding linoleic acid rich diets to rats
[39] [161], indicating an ability to increase prost¬
anoid synthesis via an increase in precursor. Further¬
more, experiments with the cyclo-oxygenase inhibitor,
indomethacin which blocks prostanoid synthesis, removed
the antiarrhythmic effect of linoleic acid rich diets
[71 ].
The results in Chapter 4 showed no increases in
arachidonic acid levels on feeding linoleic acid rich
diets (40 and 30% energy fat), when an antiarrhythmic
effect was present. Furthermore, the prostanoid inhib¬
itor aspirin did not prevent the action of linoleic
acid rich diets [71]. Indomethacin is known to have
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many side effects, including hypertension and hyper-
glycaemia [168], both of which are linked with coronary
heart disease. Therefore, a repeat experiment, using a
more specific prostanoid inhibitor with fewer side
effects was designed to reassess the previous findings.
The previous experiment using indomethacin used a
very large dose of the inhibitor (10mg/kg) which was
injected intraperitoneally one hour prior to study
in the invivo model. Therefore, the action of the drug
was not necessarily just on the heart. It could have
effected other organs which in turn caused arrhythmias.
To eliminate this problem the action of the drug on the
incidence of VF could be monitored on the Langendorff
perfusion system with the inhibitor added to the
perfusate. Furthermore, the minimum dose of inhibitor
used in this experiment would be identified by a dose
response curve, measuring a reduction in prostacyclin
production.
Flurbiprofen was the prostanoid inhibitor chosen
as it is more specific and has fewer side effects
[169]. The particular compound used was Froben (sodium
flurbiprofen), produced by the drug company, Boots
(Figure 6.1).
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FIGURE 6.1 Chemical structure of flurbiprofen
6.2 Methods.
6.2.1 Method to measure the dose response curve of
flurbiprofen,
The sodium salt of the drug was used because it
is readily soluble in the modified Kreb-Heinsleit per¬
fusate. The dose of 1 0-^ M has been documented to
inhibit prostanoid production [170] [171]. To confirm
that this was the minimum dose required to inhibit
prostanoid production in the rat heart, three doses of
— 7 — c. _ c
drug were selected, 10 ,10 and 10 M.
A 40% energy fat diet with a P/S ratio of 0.3 was
calculated and made up as in Section 2.2. Twentyfour, 8
week old, male Lew rats were placed on the diet. After
8 weeks the animals were perfused on the modified
Langendorff system (Figure 6.2). The modified system
allowed perfusion of hearts with and without drug con¬
comitantly, avoiding cross contamination. Perfusate was
collected on reperfusion and treated for prostanoid
measurement (Section 2.3.8).
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FIGURE 6.2 Modified 8 channel Langendorff perfusion
system.
* • ■'' 1 ■ •-•••^5^^
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The results of prostanoid measurement for the 3
doses are shown in Table 6.1, as percentage reduction
in prostacyclin production as measured by the
metabolite 6-oxo F. as compared to the untreated
control rat heart.
TABLE 6.1 Percentage reduction in 6-oxo F^o







# Values were less than the minimum standard for the
radioimmunoassay.
_5
The results confirmed 10 as the minimal dose
which caused maximal prostaniod inhibition.
6.2.2 Method to study the effect of flurbiprofen on the
incidence of VF in rats fed diets high and low linoleic
acid diets.
40% energy fat diets with a P/S ratio of 0.3 and
2.0 were calculated and made up as in Section 2.2. One
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hundred and sixty, 8 weeks old, male rats were placed
randomly on the two diets at staggered time intervals.
After 8 weeks, the animals were perfused as described
in Section 6.2.1. Perfusate was collected for prost¬
anoid measurement at each coronary flow measurement
(Figure 2.8 ; Section 2.3.8). Reperfusion coronary flow
was also collected for noradrenaline measurement (Sec¬
tion 2.3.9). Adipose and heart tissue were taken for
fatty acid analysis. All perfusion experiments were
treated with the exclusion criteria (Section 2.4.2) and
the remaining results were analysed using the statis¬
tics stated in Section 2.5. Noradrenaline was measured as
described in Section 2.3.9. Prostanoid samples, pre-
occlusion, 10 minute occlusion and on reperfusion were
analysed for prostacyclin (Section 2.3.8).
6.3 Results.
6.3.1 Arrhythmias.
The difference in the incidence of both VF and VT
between the low and high P/S ratio fed rats reached
statistical significance in both the untreated and
treated groups (Figure 6.3 ; Figure 6.4). The duration
and onset of both VF and VT did not differ between the
diets.
The percentage reduction in coronary flow also
showed no significant variations between any of the
dietary groups, confirming that the degree of occlusion
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was not a confounder in the results of VF and VT.
FIGURE. 6.3 - Incidence of VF in isolated rat hearts
after coronary artery occlusion, with and without
flurbiprofen.
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FIGURE 6.4 - Incidence of VT in isolated rat hearts






Significant after Chi-square test. *, Y p<0.05
6.3.2 Production of the prostacyclin metabolite
6-oxo from the isolated rat heart.
6-oxo F^ production pre, during and after cor¬
onary artery occlusion for the untreated rat hearts
showed no significant increases with the linoleic acid
rich diet (Table 6.2). 6-keto F^ production was mark¬
edly inhibited by flurbiprofen as all values were less
than the minimum standard (Data not shown).
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TABLE 6.2 Prostacyclin production in the isolated rat



















6.3.3 Reperfusion induced noradrenaline release in
isolated perfused rat hearts rats fed high and low
linoleic acid diets.
noradrenaline release between high and low P/S ratio
diets, although a trend towards an increase after
feeding linoleic acid rich diets is seen (Table 6.3).
Flurbiprofen did not effect myocardial noradrenaline
overflow either.
No significant differences were seen in
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TABLE 6.3 Noradrenaline recovered (pmol/g/min) on
reoerfusion in isolated perfused rat hearts fed high
and low linoleic acid rich diets.
Control Flurbiprofen








6.3.4 Fatty acid composition of myocardial
phospholipids.
Flurbiprofen did not effect phospholipid fatty
acid composition in any way. Analysis of the fatty acid
composition of total phospholipid and the 5 phospho¬
lipid fractions identified the same fatty acids which
were significantly different between high and low lin¬
oleic acid diets as Chapter 4, i.e. 20:2(n-6) in PE and
PC, 22:4(n-6) PE and 18:2(n-6) in PC.
6.3.5 Fatty acid composition of adipose tissue.
Flurbiprofen did not alter adipose tissue fatty
acid composition. The results confirmed the findings of
chapter 4, with statistically significant differeces in
18:0, 18:1(n-9), 18:2(n-6), 20:2(n-6) and 20:3(n-6)
between P/S ratio 0.3 and 2.0 diets.
1 60
6.3.6 Measurements to assess ischaemia.
Differences in initial, 15 minute occlusion and
reperfusion coronary flow between the drug and non drug
treated groups were found (Table 6.4). These variations
did not correlate with the incidence of VF, thereby
removing this as a possible confounder to the
arrhythmia results.
TABLE 6.4 Staistically significantly different coronary
flows (ml/min/g) after feeding high and low linoleic
acid diets and with and without flurbiprofen
Coronary flow
Control Flurbiprofen
































Identical symbols indicate significant differences
(p<0.05) in the horizontal plane after unpaired t-test.
6.4 Discussion.
Flurbiprofen inhibits the release of the
prostacyclin metabolite 6-oxo F^ but does not alter
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the antiarrhythmic effect of linoleic acid rich diets,
as has been described previously with indomethacin
[71]. These results suggest, that the doses of indome¬
thacin in previous experiments, could have induced
arrhythmias. The previous experiments used the anaethe-
tised, ventilated intact animal model and inhibition
of prostanoids could have stimulated noradrenaline
overflow by removing prostanoid neuromodulatory action.
Work on isolated papillary muscles showed that indome¬
thacin had no effects on epinephrine induced tachycar¬
dias [172] when animals had been fed linoleic rich
diets, thus supporting the view that prostanoids were
not involved in the antiarrhythmic mechanism.
The variation in coronary flows could be the
result of the length of time taken to hang and stitch
the 8 hearts or a property of flurbiprofen. The non-
drug treated hearts were always hung and stitched first
to prevent any cross contamination of the prostanoid
inhibitor. The control hearts always had a lower flow
than the drug treated hearts possibly because of
oedema, which has been documented to occur after 20
minutes of normal perfusion with protein free perfusate
on the Langendorff system [173]. The coronary flows for
the drug treated hearts were also lower than other
studies (p<0.05 ; see Chapter 8). However during occlu¬
sion the differences are not found thereby suggesting
odema is not the cause. Whatever, the reason for the
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difference no correlations were found between the flow
rates and the incidence of VF either between or within
an experimental group, thereby eliminating this as a
confounder of the arrhythmia results.
Neither the diet nor the flurbiprofen significan¬
tly altered noradrenaline overflow. The very high stan¬
dard deviations are probably because of the experi¬
mental model which does nor allow ischaemic flow to be
controlled. This could be overcome if another model of
global ischaemia such as developed by Dart et al [174]
had been used. But, such a model would not allow study
of ischaemic arrhythmias. Therefore until further
studies the overall conclusion is that noradrenaline
does not play a role in the dietary effects on
arrhythmias studied in our model. Work using the model
described above has shown that these diets do not show
a significant increase in noradrenaline after nerve
stimulation [175].
Prostacyclin measurements corroborate the
previous findings in that there is a trend towards a
reduction in release of prostacyclin in the hearts fed
linoleic acid rich diets [73]. No differences were seen
between pre, occlusion and reperfusion levels. The
release of prostacyclin measured was much higher than
the previously published results [150] [176]. The
differences in values could be caused by increased
stimuli for prostanoid production from the E.C.G. elec-
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trodes, the occlusion of the coronary artery or by the
concentration of potassium used in this experiment. A
recent publication has documented a greater production
of 6-oxo during ischaemia [176], which is also
larger than the values previously published by DeDeckre
[150] and a relationship between K+ and 6-oxo F.d has
been published [177]. Furthermore, prostanoids are
notoriously unstable and the methoxylation of the
samples immediately on collection could give the true
measurement of prostanoid release, previously lost due
to rapid breakdown.
The significant reduction in the incidence of VT
in this experiment confirms the trends observed in
previous experiments and illustrates that dietary lino-
leic acid can alter VT as well as VF.
The identification of the same myocardial fatty
acid compositional changes in phospholipid as Chapter 4
re-emphasises their importance in the antiarrhythmic
mechanism of linoleic acid rich diets. The results from
the adipose tissue further identify 18:0, 18:2n-6 and
20:3(n-6) as indicators of VF.
In conclusion it appears that the mechanism by
which linoleic acid rich diets reduce the incidence of
arrhythmias is not via modification of prostanoid
release of the 2-series. This poses the question of
whether the antiarrhythmic effect is a general
phenomenon of all polyunsaturated fatty acids or just
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caused by the n-6 family.
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CHAPTER 7




The most abundant natural source of (n-3) polyun¬
saturated fatty acids is fish, present predominantly
as 20:5(n-3) and 22:6(n-3). Several reports have iden¬
tified a lower incidence of coronary heart disease in
populations where fish is a staple constituent of the
diet [15] [178] [179]. Fish consumption is thought to
alter thrombosis and atherosclerosis via alterations in
platelet and smooth muscle function through a switch in
prostanoid production from the 2 to the 3 series [180]
[181]. This change would result in increased antiaggre¬
gatory and vasodilatory effects, possibly alleviating
both atherosclerosis and thrombosis.
Three studies have been published on the effect of
(n-3) polyunsaturated fatty acids on the incidence of
arrhythmias [121] [122] [125]. Each study has used
different amounts of dietary (n-3) polyunsaturated
fatty acids, methods of arrhythmia study, species of
animal and group sizes so comparisons between the
studies are difficult. No significant differences in VF
were found in either dogs or pigs after feeding diets
containing 25% or 29% kcal fish oil [122] [125]. A
trend was found towards a reduction in infarct size in
the dog model, but this was probably due to the method
used to induce coronary occlusion. Mo data were presen¬
ted on the extent of thrombus formation in this study
and the reduction in infarct size may simply be due to
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a decreased rate of thrombus formation. The third study
showed a reduction in both ischaemic and reperfusion VF
after feeding diets containing 30% kcal fish oil [121],
The group sizes used in this experiment were very small
(n = 8) and a reduction in VF was only observed when
compared to the extreme saturated fat diet and not the
normal chow.. The results of all of these studies are
inconclusive. Furthermore, the amounts of dietary fish
oil were extreme and could not readily be consumed in
Western society.
Ischaemic arrhythmia studies in rats using the
isolated Langendorff system are independent of athero¬
sclerosis and thrombosis, as rats are not prone to
atherosclerosis and platelets are not present in the
perfusion system. The question is whether polyunsat¬
urated fatty acids from the n-3 series exert an
antiarrhythmic effect.
The aim of this experiment was to assess the possi¬
ble antiarrhythmic effect of (n-3) polyunsaturated
fatty acids, in amounts that :-
(1) have been associated with a reduction in coronary
heart disease in man [182].
(2) could be consumed either as one to two meals a week
or as a fish oil supplement [178] [183] [184].
(3) raised myocardial phospholipid (n-3)
polyunsaturated fatty acid levels [81] [182] [184].
The amount of fish oil to be given to the rats was
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calculated according to the average food intake of a
rat from Bantmin and Kingman [185]. The experiment was
also designed to limit any effects from the confounding
influence of lipid peroxidation by administering the
fish oil through gastric stomach tubes.
7.2 - Methods.
7.2.1 - Minimum dose required to change (n-3)
polyunsaturated fatty acids in myocardial
phospholipid.
The effect of 3 doses of fish oil (Marinol; South
Africa ; Table 7.1) equivalent to 0.1%, 0.2% and 0.4%
energy fat on the fatty acid composition of myocardial
total phospholipid was studied. The actual volumes of
pure fish oil required were calculated to range from
0.021 ml to 0.096 ml per day, making administration of
such small volumes extremely inaccurate. By combining
the fish oil with the olive oil from the basic fat
mixture (P/S=0.3, 40% energy fat) 0.5 ml to 0.7 ml
could be given daily. For practical reasons oral sup¬
plements were given 5 days a week. Control animals were
also orally dosed with olive oil to reduce any influ¬
ence of stress on the results. The weekend diet
included the olive oil which would normally have been
administered orally.
Twenty four, male Sprage Dawley rats at 8 weeks of
age were placed on the diet. Six animals per group were
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placed on 1 of the 4 supplements (i.e. 0,0.1%, 0.2% or
0.4% kcal fish oil). After 8 weeks of dosing the ani¬
mals were anaesthetised, the hearts rapidly removed,
the atria trimmed off and the ventricles stored in
liquid N2. The fatty acid compostions of heart total
phospholipid were analysed by GLC.
The results identified significant differences,
which varied, depending on the dose of fish oil used
and the n-3 polyunsaturated fatty acid. The level of
20:5(n-3) in total phospholipid increased after supple¬
mentation with 0.2 and 0.4% kcal fish oil (Figure 7.1),
whereas the level of 22:6(n-3) was only significanctly
increased at the highest dose of 0.4% supplementation
(Figure 7.2). Therefore, the dose chosen for further
experiments was 0.4% energy fish oil, which was the
minimum level required to change both 20:5 and 22:6 (n-
3) in myocardial total phospholipids.
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TABLE 7.1 Fatty acid composition of Marinol fish oil
Fatty acid Amount





















FIGURE 7.1 The effect of 0, 0.1, 0.2 and 0.4% kcal























FIGURE 7.2 The effect of 0, 0.1, 0.2 and 0.4% kcal

























7.2.2 Method to study 0.4% kcal fish oil
supplementation and ischaemic arrhythmias.
Forty male 8 week old Lev/ rats were placed on the
diet described in section 7.2.1. 50% of the animals
were orally supplemented with 0.4% fish oil in olive
oil the remainder orally dosed with olive oil alone
(the controls). After 8 weeks of oral administration (5
days a week), the incidence of serious ventricular
arrhythmias during acute coronary artery ligation v/as
determined using the standard method and procedure
described in Section 2.4.2. All the results were
treated v/ith the exclusion criteria and the remaining
results were analysed using the statistical methods
described in Section 2.5.
7.3 - Results.
7.3.1 Arrhythmias
The incidence of VF, but not VT showed a trend
towards a reduction with a 0.4% dietary supplement of
fish oil (Figure 7.3) but a 5% level of significance
was not reached. The onset and duration of VF showed a
similar nonsignificant antiarrhythmic trend (Table
7.2 ) .
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FIGURE 7.3. - The effect of 0.4% dietary fish oil on






N.S. after Chi-square test.
TABLE 7.2 Onset and duration of ischaemic VF in rats
fed 0.4% fish oil vs no fish oil.
Control Fish oil
Onset VF 10.8 11.5
(minutes) (1.8) (1.7)
Duration VF 7.7 7.3
(minutes) (3.1) (3.1)
N.S. after Mann-Whitney test.
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The area of myocardium affected by coronary artery
ligation did not differ as assessed by the percentage
reduction in coronary flow, thereby removing any
influence from this confounder.
7.3.2 Levels of myocardial phospholipids.
The relative amounts of both total phospholipid
and the individual phospholipid fractions were not
influenced by dietary fish oil supplementation. (Table
7.3 ) .
TABLE 7.3 Myocardial phospholipid levels (ug fatty
acid/ g wt weight heart) with and without 0.4% fish oil
supplement.
Phospholipid Class Control Fish oil
TPL 1 4070 (3430) 1 3524 (2126)
PI 641 (256 ) 567 (136)
PS 41 7 (133) 36 0 (121 )
PC 6737 (171 1 ) 5669 (857)
PE 4707 (1 303) 4097 (592)
CL 2565 (719) 21 79 ( 324 )
(N.S. after ANOVA)
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7.3.3 Fatty acid composition of myocardial
phospholipids.
Fish oil markedly altered the fatty acid composi¬
tions of all the myocardial phospholipid classes except
PS (Table 7.4). In general terms, n-3 polyunsaturated
fatty acids increased and n-6 polyunsaturated fatty
acids decreased (Table 7.4)
7.3.4 Fatty acid composition of adipose tissue.
There were no statistically significant differ¬
ences in the fatty acids in adipose tissue except for
the trace amount of 22:6(n-3) which paradoxically
decreased from 0.06% to 0.04% after feeding fish oil.
7.3.5 Heart rate.
There were no variations in heart rate either
before or during occlusion.
7.3.6 Measurements to assess ischaemia.
Coronary flow, lactate and LDH measurements showed
no alterations after fish oil supplementation.
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TABLE 7.4 Statistically significantly different
myocardial phospholipid fatty acids (ug/gram wet weigh
heart tissue)after 0.4% fish oil supplementation.
Control Fish Oil
n-3
20:5(n-3) TPL 6.6 (2.8) 28 (14)*
PC 3.6 (4.7) 16.4 (10.4)$
PE .89 ( .77) 10.77 (4.0)*
22:5(n-3) PI 7.3 (4) 11.7 (3.7)
22:6(n-3 ) TPL 1 488 (1 84) 1802 (199)
PI 15.77 (7) 23.9 (8)
PC 239 (68) 332 (87)
n-6
20:4(n-6) TPL 3882 (91 4) 301 2 (426)
PC 2409 (590) 1 836 (223)*
PE 1 296 (374) 927 (116)$
CL 1 00 (34) 57 (8)#
22:4(n-6) TPL 99.8 (24) 51 .6 (6)*
PI 3.2 (1 .6) 1 .6 (0.6)
PC 27.9 (8.3) 13.2 (2.5)*
PE 60.0 (16) 30.0 (2)*
CL 1 .1 ( .9) 0.17 ( .28)$
22:5(n-6) TPL 220 (56) 56 (3)*
PI 2.12 (1 .2) .31 1 ( .39)#
PC 35.5 (11 ) 9.7 (2)*
PE 1 61 (42) 40 (4)*
CL 18.9 ( 5) 4.2 (1.8)*
n-9
18:1(n-9) PE 288 (68) 231
CL 250 (63) 200
20:3(n-9) TPL 1 .47 ( .36 ) .756
PE .680( .591 ) .209
(34)
(26)
All fatty aicds significant at P<0.05 ; $ p<0.01
p<0.005 ; * p<0.001.
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7.4 Discussion.
Dietary fish oil supplementation at as low a dose
as 0.2% energy fat increased the level of 20:5(n-3) in
myocardial total phospholipid (p<0.05), but a larger
dose of 0.4% energy was necessary to increase 22:6(n-
3). These amounts of fish oil are equivalent to 10 and
15 ml per day, in man, and easily achievable. The
increased incorporation of fatty acids from fish oil
into myocardial phospholipids appears not to be a ran¬
dom event. The significant increases in 20:5(n-3) were
in total phospholipid, PC and PE. Marinol has substan¬
tial amounts of 22:6(n-3), but the increases found in
this fatty acid in myocardial phospholipid were not as
marked as those for 20:5(n-3). A possible reason for
this finding is the relatively small amount of dietary
22:6(n-3) when compared to the actual amounts present
in the myocardial phospholipids. 20:5(n-3) is known to
compete directly with 20:4(n-6) for incorporation into
phospholipids [186]. The results in this chapter agree
with previous findings, in that an increase in (n-3)
polyunsaturated fatty acids causes a corresponding
decrease in 20:4(n-6) in heart phospholipids after
feeding fish oil [136] [187] [188], However, 20:4(n-6)
was not the only Cn-6) polyunsaturated fatty acid which
decreased. Its elongation-desaturation products,
22:4(n-6) and 22:5fn-6), also showed similar significant
reductions. The decreases in (n-6) PUFA' s were far
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greater than the increases in (n-3) PUFA1 s thus sugges¬
ting that the process was not simply competition.
Furthermore, the CL fraction showed decreases in both
(n-6)PUFA's and (n-9) monounsaturated fatty acids with no
corresponding increase in(n-3)PUFAs. Dietary supplemen¬
tation of fish oil, therefore, appears to alter the
substrate specificity of the enzymes involved in biosy-
nthesising specific phospholipid molecules.
Increases in the levels of 22:6(n-3) occurred
predominantly in the PC phospholipid fraction, whereas
the PE fraction showed maximal 20:5(n-3) incorporation.
Furthermore, the greatest number of fatty acid alter¬
ations were seen in the PE fraction. The susceptibility
of PE to dietary fish oil modifications has already
been identified by previous workers [76]. These results
differ from the changes seen after feeding n-6 PUFA's
in that very small amounts of n-3 PUFA's induce large
changes in the myocardium and that PE rather than PC is
the major phosphlipid fraction which is altered.
The results from the perfusion experiments demon¬
strated a nonsignificant trend towards a reduction in
the incidence of VF after only 8 weeks feeding (oral
dosing 5 days out of 7). A similar antiarrhythmic trend
was seen for both duration and onset of VF. The incide¬
nce of VT was unaffected by fish oil, as was the inci¬
dence of reperfusion VF (mean = 90 %). These results
contradict the findings of Charnock et al [121], who
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found fish oil reduced reperfusion as well as ischaemic
VF. One reason for this variation could be the diff¬
erent experimental models used, the Langendorff in-
vitro system and the intact in-vivo model used by the
Australian group. Perhaps reperfusion arrhythmias may
be dependant on the presence of certain circulating
factors present in the intact model.
This experiment only had group sizes of 20 (due
to limited availabilty) and perhaps significance would
have been reached with larger groups. Further experi¬
ments with larger groups, longer dosing periods and
larger doses were carried out, but an extremely low
incidence of VF in the control groups prevented any
comparisons from being made. However, recent experi¬
ments in our department have shown that extreme amounts
of fish oil (7% of total dietary energy as fat) resul¬
ted in a statistically significant reduction in the
incidence of ischaemic VF [189].
The absence of changes in levels of 20:5(n-3) in
adipose tissue identifies the specificity of 20:5(n-3)
for membrane phospholipids. 22:6(n-3) in adipose tissue
did show statistically significant alterations after
fish oil supplementation, but there was a reduction,
not an increase, as would be expected. The mechanism
and biological function of this change is obscure.
The use of Sprague Dawley rats and Lew rats in
this experiment identified a significant difference in
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the amounts of 22:6(n-3) in the total phospholipid of
myocardium (p<0.01). The increased level of 22:6(n-3)
in the Sprague Dawley rats may be linked with their
reduced incidence of VF, but further experiments would
have to be carried out to test this statement further.
In conclusion, these results identify the capabi¬
lity of very low amounts of fish oil to change the
composition of myocardial phospholipid. The perfusion
results suggest an antiarrhythmic effect, but the re¬
sults are not significant. Further experiments, with
longer time periods of oral dosing and possibly
increased amounts of fish oil, may give more conclusive
results and establish that the antiarrhythmic effect of
fish oil can be achieved by a realistic change in the
average Scottish male's diet. Dietary fish oil does
appear to be a more potent method of altering the fatty
acid composition of myocardial phospholipids than
dietary n-6 PUFA's. Fish oil administration is, also a
more efficient method of altering tissue arachidonic
acid levels, and hence prostanoid production.
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CHAPTER 8
THE STABILITY OF THE CORONARY ARTERY LIGATION MODEL




Thejeffectiveness of any antiarrhythmic effect is
dependent on the comparison between intervention and no
intervention. This negative control and its properties
affect the design of the experiment, particularly the
group size and the interpretation of results.
The choice of highly inbred rats, housed in ther¬
mostatically and day-length controlled conditions and
fed a strictly controlled semi-synthetic diet provided
an opportunity to study retrospectively the requirement
of a contemporary, as opposed to a historical control
group. Furthermore, the very large data base available
for the contemporary control group over the 3 year
period allowed examination of the factors, other than
diet, which .influence serious ventricular arrhythmias
in the isolated perfused rat heart.
8.2 - Methods.
All control animals (male Lew rats) were fed a
semi-synthetic diet containing 40% energy from fat and
with a P/S ratio of 0.3 for 8 weeks. The animals were
housed as described in Section 2.1. Six control groups
were studied over the period May 1987 - January 1989
(Table 8.1). The incidence of serious ventricular
arrhythmias was studied after coronary artery occlusion
using the standard procedure (Section 2.4). The results
of all the measurements made during perfusions, and the
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fatty acid compositions of both adipose and myocardial
phospholipid were combined to investigate any relation¬
ship between these parameters and the incidence of
ischaemic VF. One exception was the absence of the
phospholipid data in study 2, from which no tissue was
analysed as the arrhythmia results were inconclusive
and fatty acid data was already available for the
particular dietary intervention. All results were ana¬
lysed using the statistical criteria stated in Section
2.5.





















The incidence of both VF and VT showed a signifi¬
cant variation over the 3 year period, the overall
level of significance being p<0.001 (Figure 8.1) and
p<0.005 (Figure 8.2) respectively. The duration of both
VF and VT also differed (Table 8.2). A correlation was
found between the incidence and duration of VF
(r=0.904; p<0.01). Onset of VF also showed significant
changes, but no difference was seen in the onset of VT.
No significant correlations were found between the
onset and the severity of VF.
FIGURE 8.1 Incidence of VF in the control groups over 3
year period after acute coronary artery ligation.
5/87 8/87 10/87 12/87 4/88 1/89
study
Identical symbols indicate significance between the 2
groups after Chi-square test, abg p<0.05 ; fj p<0.005 ;
ehi p<0.001.
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FIGURE 8.2 Incidence of VT in the control groups over a
3 year period, following acute coronary artery
ligation.
abe cc^
1 2 3 4 5 6
5/87 8/87 10/87 12/87 4/88 1 /89
study
Identical symbols indicate significance between 2
groups after Chi-square test, ef p<0.05, ab p<0.01,
cd p<0.005.
The incidence of reperfusion VF over the 3 year
period showed no statistical variation, with a very
high value throughout ranging from 93% to 100%.
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TABLE 3.2 Onset of VF and duration of VT and VF
(minutes) after acute coronary artery ligation.
Study Onset of VF Duration of VF Duration of VT
1 15.03 7.61AD 0.52 acfh
(4.7) (3.3) (0.8)
2 12.82 1.01BE 0.16bdgi
(3.6) (2.4) (0.1)
3 11.10x 5.70ABCF 0.55abc
(2.7) (4.3) (0.6)
4 13.21xy 4.21C 0.91cde3
(2.4) (3.9) (0.9)
5 13.11 0.10DEG 0.08fg
(2.9) (0.02) (0.1)
6 11 .7 4y 2.49FG 1.31hig
(2.6) (3.1) (2.2)
Identical symbols indicate significance between 2
groups in the vertical plane after Mann Whitney test.
x,B,C,E,G,h,j p<0.05; y,a p<0.01; 0,F,b,e,i p<0.005;
a,c,d,f,g, p<0.001.
8.3.2 Coronary flow.
Basal and ischaemic coronary flows differed
between the studies (Table 8.3), as did the percent
reduction in coronary flows after occlusion (Table
8.3). These differences in flow were not due to diffe¬
rences in heart weight (mean value = 1.00 +_ 0.09) and
were not related to the incidence of VF, thereby remo¬
ving flow as a confounder in the arrhythmia results.
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TABLE 8.3 Coronary flow in rat hearts fed control
diet, before and during 20 minutes coronary artery
occlusion (ml/min/g).
STUDY
1 2 3 4 5 6*
pre 9.6a 10.1b 9.4° 9.0de 10.3df 7.8abcef
occl. (1.9) (2.9) (1.8) (2.5) (2.2) (2.2)
5min 6.9abc 6.5d 6.9efg 5.5bdf 5.9ae 5.7cg
occl. (1.5) (2.1) (1.4) (2.0) (1.8) (1.9)
1Omin 7.9abcd 6.2ae 7.2efgh 5.5bf 5.7cg 6.1dh
occl. (1.8) (2.0) (1.4) (2.1) (2.0) (2.0)
15min 7.9abc 6.2 6.5d 5.9a 5.8b 5.6cd
occl. (3.1) (2.1) (1.9) (2.6) (1.8) (2.1)
c. -7 -7b 0cd -i ce ncf . n ,-abdef
reper. 6.6 7.7 6.8 7.6 7.9 10.5
(2.6) (2.3) (2.0) (2.6) (2.1) (2.7)
reduct 24a 35bcd 26bef 39eg 42acfh 28d9h
(%) (31) (9.7) (10.5) (11) (14) (12)
oper RAR CS SR CS CS CS
identical symbols indicate significance in the
horizontal plane. * = 8 hearts hung per experiment
as opposed to 4.
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8.3.3 Lactate and LDH production.
No significant differences were found in initial
lactate production, demonstrating that all preparations
were undamaged. Significant differences were found in
LDH release as well as lactate production 5 and 15
minutes after occlusion and on reperfusion (Table 8.4).
Neither ischaemic lactate nor LDH correlated with the
incidence of VF, suggesting that these parameters were
not linked with the variation in arrhythmias. In fact
the lactate concentration in the coronary effluent
correlated with the reduction in coronary flow at 5
minutes (r=-0.839 ; p<0.01), but not thereafter. On
reperfusion both lactate and LDH correlated with the
reperfusion flow ( r=0.759 ; p<0.05, r=0.738 ; p<0.05
respectively).
8.3.4 Perfusate conditions.
Gassing conditions, temperature and the ionic
concentration of the perfusate could have been respon¬
sible for increases in lactate production and alter¬
ations in coronary flow. However, they were constant
throughout the 3 year period (Table 8.5). The temper¬
ature stated was monitored from the gassing chamber,
not directly at the heart, so that the optimal temper¬
ature required in the chamber to ensure 37°C at the
heart was 40°C.
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TABLE 8.4 Statistically significant lactate and LDH
production after coronary artery occlusion.
STUDY LACTATE LDH
5min 15min Reperfusion Reperfusion
occlusion occlusion
(uM/rain/g) (U/min/g)
1 0.56ade 1 .20d 1.67hk 0.45
(0.19) (0.80) (0.77) (0.16)
2 * * 2.50acj 0.89afg
(0.53) (0.35)
3 0.66b 0.95b 1.90cl 0.53b
(0.32) (1.11) (0.90) (0.23)
4 0 .77e 1 .1 2a 2.50bi 0 .67b
(0.30) (0.81) (1 .21 ) (0.27)
5 0.85ab 0.53abcd 1 .98abhi 1.33ag
(0.35) (0.23) (0.40) (0.46)
6 0 .78d 0.94° 2.71jkl 1 .22f
(0.25) (0.78) (0.72) (0.39)
Identical symbols indicate significance between 2
groups in the vertical plane. b,c,p<0.05; d,e,p<0.01;
f,g p<0.005; a,h,i,j,k,l p<0.001. * lactate
measurements at 5 and 15 minutes occlusion were not
taken for study 2.
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TABLE 8.5 Gassing, temp and PH of the perfusates









No differences were found between the heart rates
during occlusion (mean value 207 _+38 beats/min).
Initial mean heart rate varied between 222 _+43 and 261
_+39 beats/minute (p<0.05 ; Table 8.6). The reduction
in heart rate after occlusion also varied, with the
largest reduction occurring in the experiments with
high inital heart rates (Table 8.6). The variations in
initial heart rate and percent reduction of heart rate
showed no correlations with the incidence of VF,
suggesting that this parameter was not linked with the
variation observed in VF.
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TABLE 8.6 - Initial heart rate and percentage
reduction in heart rate after acute coronary artery
ligation.






1 a239 (22) be5.5 (9.8)
2 b243 (28) a1 1 (11.8)
3 c232 (40) cf 5.5 (11.8)
4 d242 (35) efg1 2 (10.5)
5 abcde261 (39) bcd1 5 (11.9)
6 e222 (43) ad^5.2 (10.9)
Identical symbols indicate significance between 2
groups in the vertical plane after upaired t-test.
a,e,f,g, p<0.05; p<0.005; c,d p<0.001.
8.3.6 Adipose tissue fatty acid composition.
No significant differences were found in the
fatty acid composition of adipose tissue throughout the
3 year period (mean 18:2£i-61 = 14.2 % _+1 .1 ) .
8.3.7 Myocardial phospholipid fatty acid composition.
Significant differences were seen in 20:5(n-3),
22:6h--3), 20:4(h-6)and 18:2<h-6)in the phospholipid
fractions and TPL (Table 8.7).
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TABLE 8.7 Statistically significant fatty acids in
myocardial phospholipids.
STUDY





























































































































Identical symbols in the horizontal plane indicate
statistical significance after unpaired t-test. p<0.05
; n=8 per group. N.B. phospholipid data from study 2
was not analysed, as the fatty acid compositions of all
the dietary interventions were already known.
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None of the statistically significant differences
correlated with the incidence of VF and are therefore
unlikely to explain the variations in the incidence of
VF and VT.
8.4 Discussion.
The arrhythmia results showed that VF and VT were
succeptible to variations over a 3 year period. The
variations in the incidence of VF also correlated with
the duration of VF, further emphasising the trend. No
differences were found in the incidence of reperfusion
VF, indicating its lack of response to factors which
influence ischaemic VF and thereby supporting the pre¬
sence of a different mechanism for reperfusion as
opposed to ischaemic VF [142].
Previous experimentalists have reported seasonal
variation in the incidence of VF. However, the animals
in these experiments were housed in strictly controlled
conditions to remove any such effect. Another factor
which is often thought to cause fluctuations in
arrhythmias is the diet [109], but in all these experi¬
ments the animals were fed a carefully controlled semi¬
synthetic diet. Chapter 3 identified a wide range in
the incidence of ischaemic VF in different strains of
rat and it could be possible that Lew rats were not
supplied by the breeders. Body weights and adipose
tissue fatty acid vary between the strains (Table 3.5;
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Table 3.7), but the absence of such variations in the
results in this Chapter eliminated the delivery of a
different strain. Ionic concentration of the perfusate,
specifically K+, was checked throughout the experi¬
ments, as were 02, C02, pH and temperature. Not supri-
singly no variations were found therby eliminating an
influence from experimental conditions.
Analysis of all the variables measured in the
perfusion experiments did not identify any change which
was linked to the variation in VF, although changes
were found in many of the parameters. The most striking
alterations between the studies were the coronary flow
and the phospholipids.
Variations were found in coronary flows over the 3
year period. Chapter 4 addressed the possibility of an
operator influence in occlusion. However inital
coronary flow is not influenced by operator occlusion
technique. A variation in the time taken per experiment
could effect initial flow. Indeed in study 6, where 8
hearts instead of 4 hearts were perfused per experiment
the initial coronary flows are lower. Oedema has been
documented in hearts hung on Langendorff systems per¬
fused for increasing time intervals with protein free
buffer [174]. To confirm such a statement the times to
hanging up would have had to have been recorded and a
measure of odema taken eg the wet weight to dry weight
ratio. However, the variations in coronary flow after
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occlusion are unrelated to the initial coronary flows
suggesting odema is not responsible. Differing degrees
of occlusion made by the different operators could
possibly explain the differences in occlusion coronary
flows. This is typified by the significant differences
in percentage reduction flow in coronary flow of myself
as opposed to R A Riemersma and S Rebergen. Further
studies would have to be carried out to properly iden¬
tify the mechanism responsible, but whatever the mecha¬
nism it does not influence the incidence of
arrhythmias.
The proposed variations in the degree of ischaemia
are further supported, by correlations between lactate
and LDH with coronary flows. Changes in the reduction
of heart rate again correlate with the degree of occlu¬
sion as indicated by the percentage reduction in coro¬
nary flow (r=0.975; p,0.001). Initial heart rate in
study 5 was much greater than the other studies and
also had the lowest incidence of VF (12 %), however no
correlation was found between initial heart rate and
the incidence of VF.
The variations seen in the phospholipid data are
not as easy to explain. The animals were fed identical
diets corroborated by the constancy of the fatty acid
composition of the adipose tissue. The variations in
the phospholipid were, however, in PC and PE, which
previous chapters have identified as being most suscep-
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table to dietary modifications. This data suggests that
a possible contender for the 1 unknown factor' could be
the maternal diet. Perhaps gradual alterations in the
(n-3) content of the maternal diet effect neural tissue
development, as has been proposed in some publications
[191] which inturn alters the propensity of ischamic
arrhythmias.
In conclusion this chapter confirms the recommend¬
ation of the Lambeth Convention [104], that a contemp¬
orary control group should be used in all arrhythmia
experiments. The variation in the incidence of VF
throughout this thesis indicates the relative ease with
which ischaemic VF can be altered, and confirms that
this lethal parameter can be reduced. However, the
identity of the antiarrhythmic factor in this experi¬
ment remains unknown. Stricter control, possibly at the
breeding stage, may lead to a further improvement of
this model and support the need for investigations into
the role of the maternal diet in myocardial phospho¬




The major conclusion from the experiments in this
thesis is that isocalorific diets rich in linoleic acid
reduce the incidence of ischaemic VF in the isolated
perfused rat heart during acute coronary artery liga¬
tion. This confirms the results of previous publica¬
tions on small groups of animals fed unbalanced diets
supplemented with corn oil. No effect at all was found
on reperfusion VF, implying a different mechanism for
this arrhythmia. Ischaemic VT did show a significant
reduction in its incidence after feeding linoleic acid
in 1 out of 3 experiments, but this was not a consis¬
tent finding throughout the experiments.
The fatty acid compositions of myocardial phospho¬
lipids were changed by linoleic acid rich diets. The
changes observed were solely in polyunsaturated fatty
acids, with the P/S ratio maintained unchanged throug¬
hout. The fatty acids of PC and PE were most susceptib¬
le to dietary fat alterations. In contrast, PS remained
effectively unaltered and in the PI fraction 20:3<h-9j
was the sole difference identified. There were no chan¬
ges in the overall distribution of fatty acids in the
phospholipid fractions.
Myocardial triglyceride levels were largely un¬
altered after feeding linoleic acid rich diets with the
only compositional change being 18:0. Adipose tissue
fatty acid composition was modified, with an increase
in 18:2n-6 and the saturated fatty acids 16:0 and 18:0.
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Measurement of the other parameters indicative of
myocardial function - coronary flow, heart rate, lacate
and LDH production showed no changes after feeding
linoleic acid rich diets. De Deckere had previously
reported an alteration in coronary flow after corn oil
supplementation in the isolated working heart [73].
These results suggest that isolated hearts must be
subjected to work to distinguish any variations in
coronary flow. Reperfusion noradrenaline levels were
also unaltered in animals fed linoleic acid rich diets.
A reduction in total dietary fat from 40% to 30%
on an energy basis did not effect the incidence of VF
in either the linoleic acid rich or linoleic acid poor
diets. However, at 20% energy fat the incidence of VF
was attenuated. A relationship between the fatty acid
composition of myocardial phospholipid and ischaemic
arrhythmias was found. Three fatty acids were identi¬
fied which correlated significantly: 20:2ih-6j in pe and
pc, 22:4$i-6)in pe and 18:2§i-6)in pc, these fatty acids
being only minor components of their respective myocar¬
dial phospholipids. No relationship was found between
any of the fatty acids in total phospholipids and the
incidence of ischaemic VF, thereby idicating the impor¬
tance of analysing the individual phospholipid frac¬
tions. The absence of any alterations in arachidonic
acid levels highlights variations between the results
in this thesis and previous publications. Differences
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in the amounts of fat used in the experiments could be
proposed to explain these discrepancies.
Dietary(n-3) PUFA's have been shown to dramatically
alter myocardial phospholipids [82] and this was demon¬
strated at very low doses in this thesis. There was an
increase in (n-3) PUFA's and a corresponding decrease in
(n-6)PUFA's. This observation is not merely simple sub¬
stitution as the decrease in the amount of (n-6) PUFA's
is much greater than the increase in (n-3^ PUFA1 s. There
may be an alteration in the specificity of the 2-
position of the phospholipid molecule. The PE phospho¬
lipid fraction is most susceptible to dietary (n-3)mani¬
pulations, whereas adipose tissue remains unaltered.
Fish oil (0.4% dietary energy as fat) showed a trend
towards a decreased incidence of ischaemic VF with a
corresponding decrease in duration and increased time
to onset. Experiments in our laboratory have since
confirmed the trend reported in this thesis with high
doses of fish oil (7% dietary energy as fat) showing
significant reduction in the incidence of ischaemic
VF. The clinical relevance at such a high dose is
minimal as this level would be very difficult to
achieve in man. Further long term low dose experiments
are required to determine an effective alteration in
ischaemic VF which could be relevant to man.
Diets in which both saturated and polyunsaturated
fatty acids were altered in parallel caused significant
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alterations in the fatty acid compositions of myocar¬
dial phospholipids. Saturated fatty acids as well as
polyunsaturated fatty acids were modified after feeding
such diets. The importance of such diets with respect
to the incidence of ischaemic arrhythmias could not be
assessed because of a poor basal level of ischaemic VF
in the control group. The experiment did, however,
highlight that, even when the myocardial phospholipid
fatty acid composition was altered, the incidence of
ischaemic VF could still remain effectively unaltered.
This suggests that dietary fat is only one means of
attenuating ischaemic VF and may only be effective if
another potent arrhythmogenic or antiarrhyrhmic factor
is not present.
Prostanoids are generally assumed by workers in
the field to be involved in the antiarrhythmic effect
observed with linoleic acid diets. This emanates from a
single publication, which is in itself contradictory
[71]. The results presented in this thesis strongly
indicate that prostanoids are not involved. The use of
the prostanoid inhibitor flurbiprofen resulted in a
greater than 92% reduction in prostacyclin production
with no adverse effect on the incidence of ischaemic
arrhythmias. Furthermore, the inhibition of prostanoid
formation did not cause any alteration in the fatty
acid compositions of myocardial phospholipids. Thereby
suggesting that phospholipid arachidonic acid levels
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are not a good indicator of possible prostanoid synthe¬
sis .
The identification of a strain of rat with a high
incidence of ischaemic VF suggest the possible involve¬
ment of a genetic factor. It has been documented that
different species have differing levels of susceptibi¬
lity to ischaemic VF, but this is the first report of
such a phenomenon within a species. The finding that
the fatty aid composition of both adipose and myocar¬
dial tissue differed between the different strains fed
identical diets illustrated that the control of fat
metabolism may have some involvement in the genesis of
VF. This finding may encourage the search for specific
genes responsible for an increased sensitivity to
ischaemic arrhythmias.
The widely inconsistent performance of the control
group throughout the three year period confirms that
the use of a contemporary control group is absolutely
essential in all arrhythmia experiments [109]. The
fluctuations in the incidence of ischaemic VF indicate
the presence of some potent antiarrhythmic mechanism
which is effective even when a 'bad' diet is consumed.
Obviously, if such a mechanism were identified, it
would be of great importance, but the lack of effects
on any of the experimental parameters normally measured
makes this search far from straightforward.
In conclusion, this thesis has confirmed the
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antiarrhythmic effect of linoleic acid rich diets. The
previous experiments had been carried in the in-vivo
model and a similar effect in-vitro indicate that
circulating factors are not essential for an effect.
The arrhythmia results documented in this thesis are
dependant on a low K+ concentration but the agreement
with previous findings established that linoleic acid
is not specific to potassium-sensitive arrhythmias.
Further work with fish oil may ascertain that this
effect is not solely a property of the essential fatty
acid linoleic acid. The importance of the P/S ratio has
also been highlighted but more experiments will have to
be carried out to understand this relationship fully.
The precise mechanism of the antiarrhythmic effect
remains unknown but several possibilities can be dis¬
counted. These include the involvement of prostanoids,
noradrenaline, release, changes in heart rate, coronary
flow and decreased anaerobic metabolism. Changes occur
in the fatty acid composition of individual myocardial
fractionated phospholipids, some of which correlate
with the occurrence of ischaemic VF. Alterations in
polyunsaturated fatty acids are generally assumed to
change membrane fluidity but the fatty acids identified
are very small components of the membrane phospholipids
and the P/S ratio is maintained constant throughout.
Therefore, gross changes in fluidity are unlikely to
occur. Phospholipid fatty acids are clearly highly
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regulated but their precise biological function is
still not fully understood. A greater knowledge of
membrane phospholipid function might allow an under¬
standing of the relevance of the changes mentioned
above. Fxirther investigation into factors such as
plasmalogens and lysophospholipids, both of which are
found in relative abundance in the heart, could also
give more information about the antiarrhythmic
mechanism of polyunsaturated enriched diets.
The antiarrhythmic effect of linoleic acid is
potentially of great importance to primary prevention
of sudden cardiac death in man. The dietary changes
necessary to provide such an effect can be applied
economically within a population and, furthermore,
circumvent the need to identify the individuals at
risk. Work of this nature should convince the medical
profession and government health departments that
increases in dietary polyunsaturated fat and not simply
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Supplier unless stated was Sigma chemicals.









Vitamin A (Retinol Acetate)
Vitamin D2 (Calciferol)
Vitamin Bg (Pyridoxine Hydrochloric)
Vitamin H (d-Biotin)










Ingredients for salt mix
Salt Amount (g)
Potassium chloride (KCl) 1 75
Secondary magnesium phosphate (MgHPO^.3h20) 478
Primary magnesium phosphate (KE^PO^) 237.5
Potassium bicarbonate (KHCO^) 359.5
♦
Calcium carbonate (CaCO^) 1 007
jfc
Zinc chloride (ZnCl2) 6.25
Manganese sulfate (MnSO^) 33.9
Ferric citrate (C6H507Fe.3H20)* 21 .95
Copper chloride (CuCl2.2H20) 2.35
Trisodium citrate 355 .5
Potassium iodate (KIO^) 0.035
Supplier unless otherwise stated Sigma chemicals.
* Chemicals supplied by BDH
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Appendix 3
Ingredients for fat mixes for semi-synthetic diets.
All mixtures are quoted for a 2kg batch of fat. The
amounts of fat added to the complete diet varies































103.3 mg tocopherol acetate
Appendix 4.
Ingredients required for semi-synthetic diets of
varying energies from fat.














20% energy fat ingredients.
1404g cornflour
534g casein
130g cellulose
46g salt mix
8g vitamin mix
185g fat mix
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